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ABSTRACT 
Conjugated linoleic acid (CLA) is present primarily in dairy products with many 
positive nutritional benefits. The predominant CLA isomers, cis-9, trans-11 CLA and trans-
10, cis-12 CLA, function as an anticarcinogen and body fat reducer in animal models, 
respectively. Other health benefits include roles as an immune system modulator, anti-
atherosclerosis agent and antidiabetic agent. Linoleic acid isomerase activity in rumen 
microorganisms and probiotic bacteria contributes to CLA formation. Free linoleic acid is the 
primary substrate for linoleic acid isomerase and the biohydrogenation pathway of rumen 
bacteria. There is strong interest to effectively increase the content of CLA in yogurt and 
other cultured dairy products using probiotic bacteria and unique processing methods. 
The objectives of this study were to 1) evaluate the ability of probiotic bacteria to 
convert linoleic acid (as the free or esterified fatty acid) to CLA in model systems 
characteristic of yogurt, and 2) develop yogurts with enhanced CLA content and acceptable 
quality attributes using probiotic bacteria with CLA-producing activity with and without 
conventional yogurt cultures (Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus 
salivarius subsp. thermophilus, 1:1). 
The 11 probiotic bacteria evaluated were able to produce CLA from linoleic acid in the model 
system containing hydrolyzed soy oil (1%) emulsified in milk, but not in model systems of 
unhydrolyzed soy oil (1%) emulsified in milk or 1% fat milk. The propionibacteria demonstrated 
the greatest increase in CLA content compared to other lactic acid bacteria in model system. 
A yogurt processed with yogurt cultures in conjunction with probiotic bacteria resulted 
in the greatest formation of the CLA and similar acidity, texture and flavor as the control yogurt. 
vi 
The combination of Lactobacillus rhamnosus with yogurt cultures produced a yogurt with the 
highest content of CLA and acceptable quality characteristics. The addition of yogurt 
cultures or rennet greatly increased the microbial counts and CLA content of yogurts 
processed with propionibacteria at 45 °C. The CLA formation, microbial counts, and quality 
attributes were stable over a 14-day storage time at 4 °C. Further study showed that the 
inoculation concentration of L. rhamnosus and yogurt cultures did not have significant effect 
on CLA content and texture, but affected acidity and volatile flavor compounds of yogurts. 
These findings indicate that probiotic dairy foods with enhanced CLA content and 
acceptable quality attributes can be effectively developed. The research results would help 
the food industry produce a more nutritional product for consumers. 
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GENERAL INTRODUCTION 
Conjugated linoleic acid (CLA) refers to a mixture of conjugated positional and 
geometric isomers of linoleic acid. As a functional component in dairy products, CLA have 
shown numerous nutritional benefits in in vitro and animal studies. The predominant isomer, 
cis-9, trans-11 octadecadienoic acid, functions as an anticarcinogen against several types of 
cancer (Ha and others 1990; Ip and others 1991; Cesano and others 1998). Another important 
CLA isomer, trans-10, cis-12 octadecadienoic acid, is more effective in reducing body fat 
(Park and others 1999) and protecting body weight (Chin and others 1994). Other health 
benefits of CLA include the use of CLA as an antiatherogenic agent (Nicolosi and others 
1997), an antidiabetic agent (Houseknecht and others 1998), and immune system modulator 
(Hayek and others 1999). These results have exciting implications for improved human 
health. 
Ruminant food products, especially dairy foods, are the major dietary sources of CLA 
(Chin and others 1992; Shantha and others 1994). Fermented dairy products often contain 
higher levels of CLA than nonfermented milk (Shantha and others 1995; Jiang and others 
1998; Kim and Liu 2002). Several factors, such as the CLA content of the raw milk, starter 
cultures, aging time and other processing treatments, have been shown to influence the CLA 
content of cultured dairy foods (Chin and others 1992; Lin and others 1995, 1999a; Shantha 
and others 1995). 
The consumption of CLA-enriched food products is an effective approach to increase 
human's CLA intake and obtain the potential benefits of CLA (Chamruspollert and Sell 
1999). A primary mechanism for the formation of CLA involves the biohydrogenation 
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pathway through rumen bacteria. The differences in the activity and amounts of linoleic acid 
isomerase will affect the activity of isomerization, and subsequently the CLA content of 
foods (Ha and others 1987; Chin and others 1992, 1993). 
Currently, much research has focused on the CLA-producing ability of probiotic 
bacteria in model systems with linoleic acid. The lipid source, a limiting factor during 
fermentation of dairy products by probiotic bacteria, should be further investigated. Based on 
our knowledge, there is no published research reporting the CLA formation and quality 
attributes of dairy products. Since the differences exist between the model system and dairy 
food production, the CLA formation of probiotic bacteria might be affected in real dairy 
products. 
This study was conducted to develop a yogurt with increased CLA content produced 
with probiotic bacteria. The long-term goal is to study the mechanism involved in improving 
human health through the consumption of CLA-enriched dairy products and to further 
improve the consumer acceptability of dairy foods. The first project was designed to identify 
strains of probiotic bacteria commonly used in dairy products that were able to produce CLA 
in milk model systems with different lipid sources (hydrolyzed soy oil, unhydrolyzed soy oil, 
or milk fat) at 1% fat content. Probiotic bacteria with the high CLA-forming ability were 
included as adjunct cultures to yogurt cultures in the next experiment. The second project 
focused on the incorporation of the probiotic bacteria with the conventional yogurt cultures 
to evaluate the ability of those probiotic bacteria to produce a yogurt with increased CLA 
content and acceptable quality attributes. Several processing factors including the interaction 
of probiotic bacteria with conventional yogurt cultures, inoculation level and storage time 
3 
following processing were evaluated to determine their effect on the CLA formation and 
organoleptic characteristics of the yogurt. 
Dissertation organization 
This dissertation is composed of a general introduction, a literature review, three 
papers, and a general conclusion. The literature review includes structure, biological activity, 
and sources of CLA, formation mechanisms of CLA and factors which affect the content of 
CLA, and analytical methods for CLA determination. The first paper was published in the 
Journal of the American Oil Chemists' Society in June 2004. The second paper was 
submitted to the Journal of Food Science. The third paper will also be submitted to the 
Journal of Food Science. Following the third paper are general conclusions and a list of 
references cited in the general introduction and literature review. 
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LITERATURE REVIEW 
Structure of CLA 
Linoleic acid (LA) is an 18-carbon fatty acid containing double bonds in the cis-9 and 
cis-12 configuration. Conjugated linoleic acid (CLA) refers to a mixture of conjugated 
positional and geometric isomers of LA. The conversion of LA to one isomer of CLA is 
shown in Figure 1. Ip and others (1994) identified 9 CLA isomers, which differ in the 
position and geometric configuration of double bonds (Table 1). The main double bonds of 
CLA exist at positions 9 and 11, or 10 and 12 (Ha and others 1987). The predominant CLA 
isomer in foods is cis-9, trans-11 CLA, which accounts for between 73 to 93% of the total 
CLA in dairy products (Chin and others 1992; Werner and others 1992; Parodi and others 
1996). Chin and others (1992) indicated the cis-9, trans-11 CLA isomer contributed to more 
than 83% of the total CLA isomers in natural and processed cheeses. In 1992, Werner and 
others investigated the level of CLA isomers in 3 types of cheese. The results showed that the 
cis-9, trans-11 CLA isomers accounted for 82-88% of the total CLA and the trans-9, trans-
11 and trans-10, trans-12 CLA isomers accounted for 8-11% of the total CLA. Trans-10, cis-
12 CLA is the other major fatty acid form. 
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AA/=V=WWCOOH 
cis-9, cis-12 LA 
Isomerization 
cis-9, trans-11 Conjugated LA 
Fig. 1. The conversion of LA to CLA 
Table 1. Isomer forms of CLA 
Main CLA isomers 
9, 11-isomers1 10,12-isomers 11,13-isomers 
• 2 CIS, CIS cis, cis cis, cis 
cis, trans cis, trans 
trans, cis trans, cis 
trans, trans trans, trans 
The numbers refer to the position of double bonds. 
2 The terms cis and trans refer to the geometric configuration of the double bonds. 
Biological Activity of CLA 
As a functional component, conjugated LAs have shown numerous nutritional 
benefits. Cis-9, trans-11 CLA was first found to have biological activity because it was 
incorporated into the phospholipid fraction of cell membranes. This isomer functions as an 
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anticarcinogen against several types of cancer (Ha and others 1990; Ip and others 1991; 
Cesano and others 1998). Another bioactive CLA isomer, trans-10, cis-12 CLA, can act as a 
body weight protector (Chin and others 1994; Miller and others 1994) and body fat reducer 
(Park and others 1999). Other health benefits of CLA include roles as an immune system 
modulator (Hayek and others 1999), a bone metabolism modulator (Watkins 1999), an 
antiatherogenic agent (Nicolosi and others 1997), and an antidiabetic agent (Houseknecht and 
others 1998). 
The relationship between dietary CLA and arachidonate-derived 
eicosanoids 
Arachidonic acid is the precursor of a group of hormones known as prostaglandins, 
such as prostaglandin E2 (PGE2), prostaglandin F2a (PGF2a), and prostaglandin D2 (PGD2). 
The eicosanoids derived from arachidonic acid mediate several processes required for 
tumorigenesis, including cell proliferation (induction of ornithine decarboxylase and DNA 
synthesis) and inflammation (local and systemic immune responses) (Belury 1995). PGE2 
suppresses T-lymphocyte proliferation and production of tumor necrosis factor (TNF)-a 
(Scales and others 1989). PGE2 has also been reported as a potential agent that stimulates 
bone formation and resorption (Li and Watkins 1998). 
The CLA-induced reduction of phospholipid arachidonate has been suggested to 
inhibit eicosanoid synthesis and affect tumorigenesis. Since CLA can readily be incorporated 
into membrane phospholipids, it may compete in elongation and desaturation steps with other 
polyunsaturated fatty acids (PUFA) that are precursors of arachidonic acid (the precursor of 
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PGEa). Thus, eicosanoid biosynthesis is altered due to changes in arachidonic acid synthesis 
(Abou-El-Ela and others 1989; Leyton and others 1991). Competition between CLA and 
other PUFAs is likely for the phospholipase, cyclooxygenase, and lipoxygenase enzymes. 
Dietary CLA modulation of À6-desaturase activity has also been suggested to reduce 
phospholipid arachidonate so that arachidonate-derived eicosanoids are decreased (Belury 
and Kempa-Steczko 1997). Since CLA may be elongated and desaturated to 20:4 isomers 
(Sebedio and others 1997), these isomers can compete with arachidonic acid for 
cyclooxygenase enzyme and lower PGE2 in a manner similar to n-3 PUFA. These results 
explain why CLA is able to reduce basal levels of TNF-like activity (Liu and Belury 1997). 
Thus, the effects of CLA on arachidonate-derived eicosanoids may significantly affect the 
development of cancer, immune responses, and bone metabolism. 
Carcinogenesis 
Conjugated LAs have shown anticarcinogenic effects in many studies. A mutagenesis 
modulator in fried ground beef was identified by Pariza and others (1983). This substance 
was suggested to mitigate the harmful effects of low levels of mutagens and carcinogens 
ingested with daily food consumption (Pariza and Hargrave 1985). In subsequent research, 
this substance was identified as CLA. The four major CLA isomers were cis-9, trans-ll 
CLA, trans-9, trans-ll CLA, trans-10, cis-12 CLA, and trans-10, trans-12 CLA (Ha and 
others 1987). Belury (1995) showed CLA may regulate carcinogenesis by affecting the 
different stages of cancer development, such as initiation, promotion, progression, and 
regression. 
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Several mechanisms for the anticarcinogenic properties of CLA have been proposed. 
The antioxidative activity of CLA both in vitro and in vivo may contribute to its 
anticarcinogenic effect (Ha and others 1990; Ip and others 1991; Pariza 1991). Free radicals 
are important in the tumor promotion phase of carcinogenesis (Ha and others 1990; Pariza 
and Ha 1990; Pariza 1992). CLA functions as a protective agent against the formation of free 
radicals. It has been shown to be more potent in inhibiting the formation of iron-thiocyanate-
induced peroxides (Ha and others 1990) and TEARS (thiobarbituric reactive substances) (Ip 
and others 1991) than BHT (butylated hydroxytoluene). In female Sprague-Dawley rats using 
the DMBA (dimethylbenz[a]anthracene)-induced mammary tumor model, although 0.25% 
CLA in the diet led to maximal antioxidant activity, maximal tumor inhibition was achieved 
at about 1% CLA (Ip and others 1991). Therefore, the antioxidant effect of CLA may not be 
the only mechanism in cancer protection. 
The regulation of eicosanoid synthesis by CLA also contributes to the 
anticarcinogenic properties of CLA. Arachidonate-derived eicosanoids can modulate 
carcinogenesis in the mammary gland (Abou-El-Ela and others 1989), skin (Fischer and 
others 1989), and colon (Bull and others 1989). PGEz is most frequently associated with the 
enhancement of tumor induction. Dietary CLA (0.5% w/w) was reported to partially displace 
arachidonate, a precursor of PGE2, in rat fat pad (Cook and others 1993). 
Another proposed mechanism involves the inhibition of enzymes that promote cell 
proliferation, such as ornithine decarboxylase (ODC) and protein kinase C (Benjamin and 
others 1990, 1992; Chin and others 1993). As a tumor promoter, 12-0-tetradecanoylphorbol-
13-acetate (TPA) can activate ODC and protein kinase C. Increased activity of ODC and 
protein kinase C results in cell proliferation, which may be associated with tumor promotion 
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(Parodi 1994). However, CLA inhibits the induction of mouse forestomach ODC and protein 
kinase C activity induced by TPA (Benjamin and others 1990, 1992). 
Conjugated LA also can inhibit the biosynthesis of proteins and nucleotides to 
suppress cancer cell growth (Shultz and others 1992). When human breast cancer cells were 
incubated with CLA, significantly less labeled leucine, uridine, and thymidine were 
incorporated than with control cultures. Similarly, colorectal and melanoma cancer cells 
incubated with CLA incorporated less labeled leucine (Parodi 1994). The reduction of PGE% 
at the skeletal muscle level has been reported to depress protein degradation (Rodemann and 
Goldberg 1982). The inhibition effect of CLA on the synthesis of eicosanoid may explain its 
role on the biosynthesis of proteins and nucleotides. 
Skin Cancer 
CLA, isolated from fried ground beef, inhibited the initiation of mouse epidermal 
carcinogenesis induced by DMBA (Ha and others 1987). Compared with control mice, only 
half as many pappilomas and a lower tumor incidence (20%) were observed when mice were 
treated with CLA at 7 d, 3 d and 5 min prior to DMBA carcinogen application at doses of 20, 
20, and 10 mg, respectively. Cytochrome p450 is necessary for DMBA metabolism in vitro 
to produce its ultimate carcinogenic form. The mechanism for CLA inhibition of the 
initiation of epidermal tumors by DMBA is partially due to its direct inhibition of 
microsomal cytochrome p450 enzyme activity. By modifying the carcinogen's metabolism, 
CLA can inhibit skin carcinogenesis. 
CLA also shows an inhibitory effect on tumor promotion. The role of CLA in 
modulating skin tumor promotion was investigated (Belury 1995). Mice were fed control (no 
CLA) diets during initiation, and then switched to diets containing various doses of CLA (0-
1.5% w/w) during skin tumor promotion by the phorbol ester TP A. There was an inverse 
correlation between tumor yield and CLA content in the diet during 22 weeks of TPA 
treatment. This result suggested that CLA inhibited tumor promotion in a dose-responsive 
manner. Diets containing 1.0% and 1.5% CLA inhibited tumor yield compared to diets 
without CLA or 0.5% CLA in skin tumors promoted by 12-0-tetradecanoylphorbol-13-
acetate (TPA) in mice (Belury and others 1996). CLA inhibits skin tumor promotion partially 
through a PGE-dependent mechanism. In addition, the study of multistage carcinogenesis in 
mouse skin demonstrated that TPA-induced promotion was also associated with increased 
ODC activity (DiGiovanni 1992). The increased ODC activity resulted in the synthesis of 
polyamines, which are required to stabilize increased DNA synthesis involved with 
hyperproliferative cells and tumor promotion (Pegg and others 1986; Clifford and others 
1995). Due to the inhibition of ODC activity by CLA, CLA was less able to support 
hyperproliferation induced by TPA. 
Mammary Cancer 
CLA has been shown to significantly inhibit mammary carcinogenesis. Ip and others 
(1991) were the first to report the chemoprotective effect of dietary CLA on mammary 
carcinogenesis. Dietary CLA at 0.25% or more reduced the formation of TEARS in 
mammary tissues so that mammary carcinogenesis was inhibited. This result suggested that 
CLA inhibition of mammary carcinogenesis is partially attributed to the inhibition of 
oxidative stress. A dose-responsive effect of CLA was observed. Mammary tumor incidence 
and tumor multiplicity were significantly reduced at a dietary level of 0.5% CLA and 
inhibited at a dietary level of 1% CLA in female Sprague-Dawley rats using the DMBA-
induced (10 mg DMBA in com oil) mammary tumor model (Ip and others 1994). An inverse 
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relationship was demonstrated between dietary CLA and oxidation, and between CLA and 
mammary carcinogenesis. The incorporation of CLA during mammary gland morphogenesis 
in the rat provided lasting protection against subsequent cancer risk (Ip and others 1994). The 
proliferative activity of lobuloalveolar units (sites of carcinogenic transformation) was 
reduced by feeding CLA. By reducing the proliferation of epithelial end bud cells, CLA can 
render the target cell population less susceptible to carcinogen-induced neoplastic 
transformation (Ip and others 1994). The effect of dietary fat on anticarcinogenic properties 
of CLA was further studied. The level (10, 13.3, 16.7 or 20% by weight in the diet) or type of 
fat (corn oil or lard) in the diet did not affect the cancer inhibitory efficacy of CLA (1%) in 
the rat (Ip and others 1996). 
The role of CLA in inhibiting promotion/progression of mammary carcinogenesis 
was investigated (Ip and others 1995). Since various doses of dietary CLA administered prior 
to mammary carcinogen treatment and continued through tumorigenesis inhibit mammary 
tumor incidence and yield, CLA has also been suggested to modulate the promotion stage of 
cancer in addition to initiation. Using the methylnitrosourea (MNU)-induced mammary 
carcinogenesis model, the administration of 1.0% CLA during early post-weaning and 
puberty was sufficient to reduce subsequent mammary tumorigenesis. Since continuous CLA 
intake leads to maximal inhibition of tumorigenesis, it is hypothesized that some active 
metabolites of CLA are necessary to suppress the process of neoplastic promotion / 
progression (Ip and others 1995). Further study demonstrated that 1% dietary CLA 
effectively prevented the post-initiation phase (20 weeks) and resulted in 50% reduction in 
tumor incidence, but had no effect on the initiation period of mammary cancer induced by 
DMBA in rats (Ip and others 1997). A continuous supply of CLA is necessary for maximal 
tumor inhibition in the post-initiation phase of mammary carcinogenesis. In the target organ, 
an abundant source of CLA plays a critical role in blocking or delaying tumor appearance. 
Thompson and others (1997) also reported feeding CLA during the time of mammary gland 
maturation reduced target cell vulnerability to carcinogen-induced transformations. 
The growth and mestatic spread of transplantable mammary tumors were studied. 
Dietary CLA (1.0%) administered 2 weeks prior to inoculation could block both the local 
growth and systemic spread of human breast cancer to lungs, peripheral blood, and bone 
marrow (Visonneau and others 1997). However, Wong and others (1997) found that CLA 
had no significant effect on the growth of established marine mammary tumors. 
Colon. Prostate and Lune Cancers 
The effects of CLA on tumors were also studied in other sites. The effect of CLA 
against 2-amino-3-methylimidazo [4, 5-f] quinoline (IQ)-induced colon carcinogenesis was 
studied (Liew and others 1995). In the colon of the F344 rat, CLA protected against IQ-DNA 
adducts and colonic aberrant crypt foci. Cesano and others (1998) studied the effect of three 
different diets (standard, 1% LA or 1% CLA added) on the local growth and mestatic 
properties of DU-145 human prostatic carcinoma cells in SCID mice. Mice fed the CLA-
supplemented diet displayed smaller local tumors and a drastic reduction in lung metastases 
as compared with standard diet-fed group. However, mice fed LA-supplemented diet resulted 
in significantly higher local tumor load than the other two groups of mice. Schonberg and 
Krokan (1995) indicated CLA (control, 10 (xg, 20 (ig, and 40 p.g) showed a dose-dependent 
reduction in proliferation of the lung adenocarcinoma cell lines. The results showed the 
CLA-supplemented diet led to smaller local tumors and significantly reduced lung metastasis 
in mice compared to that for the LA-supplemented diet. 
Body fat metabolism 
CLA decreases body fat accumulation and increases lean body mass in animals 
(Pariza and others 1996, 1997). The reason has been assumed that CLA affects the 
adipocytes (the major site of fat storage) and skeletal muscle cells (the major site of fat 
oxidation) to play a major role in the body composition changes. The effect of CLA on 
increased lean body mass is linked to CLA's protection against the catabolic effects of 
immune stimulation (Cook and others 1993; Miller and others 1994). 
One proposed mechanism is that CLA increases the hormone-sensitive lipase activity 
and enhances lipolysis. CLA also increases the rates of fatty acid oxidation. Dietary CLA 
supplementation increases carnitine palmitoyltransferase (CPT) activity, which is a rate 
limiting factor for fatty acid (3-oxidation (Pariza and others 1997; Park and others 1997). 
Mice fed a diet supplemented with CLA (5% corn oil plus 0.5% CLA) enhanced fatty acid (3-
oxidation in skeletal muscle and fat tissue. CLA also increased hormone-sensitive activity of 
lipase and free glycerol (22%), and reduced the activity of heparin-releasable lipoprotein 
lipase (LPL) (-66%), intracellular triacylglycerol concentration (-8%) and glycerol (-15%) 
compared to controls. The changes in enzyme activity were correlated with the reduction in 
body fat. In this study, the CLA-fed mice had lower body fat (57% in males, 60% in females) 
and increased lean body mass (5% in males, 14% in females) compared to controls. 
Therefore, decreased fat deposition was attributed to increased lipolysis in adipocytes, 
possibly coupled with enhanced fatty acid oxidation in both muscle cells and adipocytes 
(Park and others 1997). 
In the milk fat of dairy cows, a distinct pattern of fatty acids originates from de novo 
fatty acid synthesis, uptake of preformed fatty acids and desaturation of a portion of the long-
chain fatty acids. The addition of the CLA supplement increased the CLA content of milk fat 
in a dose-dependent manner from 7 mg CLA/g fat at the zero dose to 64 mg CLA/g fat at the 
high dose of 150 g/d of CLA supplement. However, the milk fat content of lactating cows 
was greatly reduced when CLA supplement was infused abomasally to by-pass rumen 
biohydrogenation (Chouinard and others 1999). Specifically, the reduction of milk fat was 
relatively greater for the short- and medium- chain fatty acids which are partially synthesized 
d e  n o v o  b y  t h e  m a m m a r y  e p i t h e l i a l  c e l l s .  I n  a d d i t i o n ,  t h e  f a t t y  a c i d  r a t i o s ,  i n c l u d i n g  C u o  
:Ci4:i,C|6:o : Ci6:i and Cig:o : Cig:i, were all increased with the CLA supplement. These results 
might be due to effects of CLA on de novo fatty acid synthesis and the desaturation process. 
More study is necessary to explore whether body fat reduction and muscle mass increase will 
occur in humans when given CLA. 
Further evidence shows CLA-associated body composition changes result from 
feeding the trans-10, cis-12 CLA, but not the cis-9, trans-11 CLA. The cis-9, trans-11 CLA 
isomer was not correlated with fat content of milk (Griinari and others 1997; Chouinard and 
others 1999). However, the trans-10, cis-12 CLA isomer inhibited the activity or synthesis of 
key enzymes involved in de novo fatty acid synthesis to decrease milk fat synthesis 
(Baumgard and others 2000). The trans-10, cis-12 CLA isomer reduced LPL activity in 
cultured 3T3-L1 adipocytes and enhanced triacylglycerol release from these cells. Both LPL 
activity and intracellular triglyceride (TG) were reduced in a dose-dependent fashion with 
addition of trans-10, civ-12 CLA (Park and others 1999). Thus, the specific CLA isomer, 
trans-10, cis-12 CLA, affects fat synthesis in the mammary gland (lactation) and adipose 
tissue (growth). 
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Immune function 
The immune modulation of CLA may be related to its effect on fat deposition and 
growth. Immune stimulants stimulate the macrophages to produce cytokines and cause 
catabolism of muscle cells (Roura and others 1991; Chamblee and others 1992). 
Lipopolysaccharide (LPS), an endotoxin, stimulates immunity and reduces growth of chicks. 
However, chicks fed CLA and injected with LPS continued to grow, while those not fed 
CLA either failed to grow or lost weight following the injection of LPS (Cook and others 
1993). CLA decreased arachidonic acid in skeletal muscle so that immune-induced catabolic 
effects were decreased. Dietary CLA had no adverse effects on immune variables and 
prevented the catabolic effects on immune stimulation in both chicks and rats (Cook and 
others 1993; Miller and others 1994). The ability of CLA to prevent endotoxin-induced 
growth suppression was also studied in mice which were fed fish oil, CLA, or a basal diet. 
The results showed that anorexia caused by endotoxin injection was effectively prevented by 
CLA. As a dietary supplement, feeding 0.5% CLA to chicks, rats, and mice decreased body 
weight loss compared to feeding 0.5% fish oil. Rats and chicks fed CLA had decreased 
muscle arachidonic acid and reduced muscle degradation compared with the basal-fed 
controls (Miller and others 1994). Like fish oil, CLA has been suggested to exert an effect on 
the immune system by altering arachidonic acid formation of cyclooxygenase or 
lipooxygenase pathway. The change in cell membrane fatty acids alters prostaglandin 
production and prevents body weight loss (Hellerstein and others 1989). 
The effect of CLA on immune regulation is independent of the type of PUFA in the 
diet. In a study, Sprague-Dawley rats were fed diets containing soybean oil or menhaden oil 
and safflower oil, with CLA (10 g/kg) or without CLA for 42 days. The effect of CLA on 
PGE2 production in spleen or liver was not affected by the type of PUFA (Turek and others 
1998). PUFA and CLA interacted to affect eicosanoid regulation of cytokine production. 
PUFA, mainly arachidonic acid, are associated with eicosanoid synthesis. CLA possibly 
interacts with LA and arachidonic acid for incorporation and biological activity in cellular 
phospholipids (Belury 1995). The interaction between CLA, LA and arachidonic acid 
influences eicosanoid production and subsequent cellular events. CLA has been reported to 
change the PUFA composition of phospholipids of cell membranes. So the inhibition of 
eicosanoid synthesis is caused by CLA-induced reduction of arachidonic acid in 
phospholipids (Belury 1995; Liu and Belury 1997). 
Bone metabolism 
A large amount of evidence has indicated that PGE potentially stimulates bone 
formation (Marks and Miller 1993; Raisz 1993). Bone tissue and cells produce IGF-I 
(insulin-like growth factor-I) and IGF-II (insulin-like growth factor-II). They are stored in 
skeletal tissue of vertebrates, such as chickens and humans (Bautista and others 1990; Isgaard 
1992; McCarthy and Centrella 1993). Although IGF-I shows lower amounts in bone than 
IGF-II, IGF-I is under greater regulatory control (McCarthy and others 1991). PGE2 
increased IGF-I transcript and polypeptide contents in rat calvaria cells (McCarthy and others 
1991; Schmid and others 1992) and stimulated the expression of mRNA for IGF binding 
protein-3 (IGFBP-3) to enhance the IGFBP-3 binding affinity to rat calvaria (Schmid and 
others 1992). The effect of dietary lipids on bone PGE2 production and bone formation in 
chicks was studied (Watkins and others 1997). Feeding anhydrous butter oil to chicks 
produced a moderate level of arachidonic acid and PGE2 in bone compared with feeding 
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soybean oil. At a moderate level (10~7 M), PGE2 could stimulate bone formation; but at a 
higher concentration (10~5 or 10"6 M), PGE2 would reduce bone formation. PGE2 has been 
recognized as a mediator of bone formation and bone resorption in vivo (Marks and Miller 
1993). The CLA source in animal fat has been suggested to produce a moderate level of 
PGE2 
CLA-derived eicosanoids can regulate the synthesis of arachidonic acid metabolites 
like PGE2. So, the effects of PGE2 on bone formation and resorption may be mediated locally 
by inducing the biosynthesis of IGF-I. This result explained why animal fats affected bone 
formation in chicks. Further study on the effects of CLA on tissue fatty acids composition 
and ex vivo PGE2 formation in rats was conducted (Li and Watkins 1998). Dietary CLA (10 g 
/ kg of the diet) lowered ex vivo PGE2 production in bone organ cultures and has the potential 
to impact bone formation and resorption. The reduction in PGE2 by CLA might be due to a 
competitive inhibition of n-6 fatty acid formation (Sebedio and others 1997). It was also 
reported that the PUFA and CLA interacted to affect eicosanoid regulation of cytokine 
production (Turek and others 1998). Therefore, CLA indicates positive effects on bone health 
by modulating cytokine production. 
Antioxidant potential 
CLA has been shown to inhibit formation of free radicals in vivo and in vitro. CLA 
showed stronger antioxidative activity than a-tocopherol and was as effective as BHT in 
inhibiting iron thiocyanate-induced peroxide formation (Ha and others 1990). In an in vivo 
rat study (Ip and others 1991), CLA was as effective as vitamin E and BHT in inhibiting the 
formation of TEARS, a biomarker often used to assess the extent of lipid peroxidation in 
biological systems, in the mammary gland. These findings indicated a relationship between 
dietary CLA, oxidation, and carcinogenesis. The reaction of CLA with peroxyl or hydroxy] 
radicals, followed by a reaction with oxygen forms an active antioxidant, P-hydroxyacrolein 
moiety. The resonance enolization of the (3-hydroxyacrolein moiety may contribute to its 
antioxidant activity. The effective chelation of iron by (3-hydroxyacrolein derivatives of CLA 
is another important mechanism to inhibit membrane peroxidation in vivo (Ha and others 
1990). The antioxidant effect of CLA may contribute to the reduction of atherosclerosis in 
rabbits (Lee and others 1994) and anticarcinogenic effects (Ha and others 1990; Pariza 1991; 
Ip and others 1991). 
However, some ambiguous conclusions still exist about the antioxidative activity of 
CLA. The protective effects of CLA (0.25 (xM, 0.50 pM, 0.75 pM) on membranes composed 
of 1 -palmitoyl-2-linoleoyl phosphatidylcholine (PLPC) from oxidative modification under 
conditions of metal ion-dependent or independent oxidation stress were studied (Van den 
Berg and others 1995). Their results demonstrated that CLA did not act as a free radical 
scavenger. Since CLA is readily converted to furan fatty acids, the antioxidant activity of 
CLA may be due to furan fatty acid, which can scavenge free radicals (Yurawecz and others 
1995; Okada and others 1996). The antioxidant effect may be due to a metabolite or oxidized 
form of the fatty acid because CLA was as susceptible to oxidation as LA (Van den Berg and 
others 1995). 
However, CLA and its metabolites have been reported to steadily decrease under 
oxidative stress and were more susceptible to oxidation than their corresponding methylene-
interrupted fatty acids (Banni and others 1998). Decker (1999) reported CLA did not directly 
inhibit lipid oxidation, but instead altered the fatty acid composition of tissues to increase 
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oxidative stability. Since the CLA used in the above research was mainly a mixture of 
isomers, the antioxidant activity of two individual isomers, cis-9, trans-11 CLA and trans-10, 
cis-12 CLA, were investigated (Leung and Liu 2000). Trans-10, cis-12 CLA demonstrated 
antioxidative activity at all concentrations evaluated (2 mM, 20 mM, and 200 mM). It was a 
more effective antioxidant than cis-9, trans-11 CLA and alpha-tocopherol at lower 
concentrations (2 and 20 mM). The cis-9, trans-11 CLA only possessed weak antioxidant 
activity at lower concentrations. At 200 mM, cis-9, trans-11 CLA functioned as a strong pro-
oxidant. However, no pro-oxidant activity was shown for trans-10, cis-12 CLA. These results 
suggested that the antioxidative activity of CLA was determined by a balance of antioxidant 
properties of trans-10, cis-12 CLA and pro-oxidant properties of cis-9, trans-11 CLA in 
different oxidation conditions and concentrations (Leung and Liu 2000). 
Atherosclerosis 
Some potent antioxidants, such as BHT (Freyschuss and others 2001) and probucol 
(Kita and others 1987) have shown antiatherogenic effects in rabbits. Since CLA has 
demonstrated antioxidant activity in vivo and in vitro, it may act as an antiatherogenic agent 
in animals. 
A study to feed hamsters a hypercholesterolemic diet supplemented with 0.05% CLA 
was conducted (Nicolosi and others 1993). In CLA-fed hamsters, a significant reduction was 
observed in plasma total cholesterol (-26%), low density lipoprotein (LDL) cholesterol (-
27%), TGs (-28%) and in the formation of fatty lesions on aortic surface compared with 
hamsters not fed CLA. Similar results were observed by Lee and others (1994) in rabbits. 
After 12 weeks, the CLA-supplemented diet significantly reduced the LDL cholesterol to 
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HDL cholesterol ratio, total cholesterol to HDL cholesterol ratio, total and LDL cholesterol, 
and TGs. The reduced plasma LDL content in the rabbits and hamsters fed CLA would 
reduce atherosclerosis (Goldstein and Brown 1977). Nicolosi and others (1997) reported that 
CLA reduced the fatty streak formation in arteries and total serum cholesterol content in 
hypercholesterolemia hamsters fed CLA (control, 0.06%, 0.11% and 1.1%). Although LA 
(1.1%) effectively reduced total serum cholesterol and TG levels, CLA (1.1%) was five times 
more effective in decreasing plaque on arterial walls. 
CLA in human body 
CLA has been identified in human blood, milk, bile, and duodenal juice (Cawood and 
others 1983; Fogerty and others 1988). The concentration of cis-9, trans-11 CLA in human 
serum and milk, has been shown to be 0.3-0.54% and 0.31-1.25% of total fatty acids, 
respectively (Fogerty and others 1988). The content of the cis-9, trans-11 CLA ranges from 
2.23 to 5.43 mg / g fat in human milk (McGuire and others 1997). 
The majority of CLA in human tissues is due to dietary intake. Fogerty and others 
(1988) showed that Hare Krishna women who consume greater amounts of butter or ghee 
produce milk with a higher CLA content (11.2 mg CLA/g fat) than do women consuming a 
conventional diet (5.8 mg CLA/g fat). Thus, dietary CLA intake can increase the CLA 
content in human milk. The content of CLA in plasma is also increased by increases of CLA 
in the diet (Huang and other 1994). The addition of 112 g Cheddar cheese (178.5 mg CLA / 
day) to diets of 9 healthy men daily for 4 weeks enhanced CLA content from 7.1 to 9.6 pmol 
/ L of plasma. The CLA content in plasma or human milk is not significantly altered through 
increased intake of LA or fish oil (Herbel and others 1998; Jensen and others 1998). Jiang 
and others (1999) reported a correlation (r=0.42) between cis-9, trans-11 CLA in human 
adipose tissue and milk fat intake. These studies indicated it is necessary to reconsider the 
positive health properties of milk fat associated with its transfer into CLA. 
Endogenous synthesis may also contribute to CLA formation in human tissues. 
Butyrivibrio fibrisolvens has been found in human fecal material (Brown and Moore 1960). 
Kepler and others (1966) reported this microorganism contains LA isomerase, which 
converts LA to cis-9, trans-11 CLA in ruminant animals. So, CLA can be formed through 
microbial biohydrogenation of dietary LA in the intestine. 
Dietary trans fatty acids can be converted to CLA to increase CLA content in human 
plasma. Salminen and others (1998) provided a dairy fat diet to healthy volunteers for the 
first 5 weeks, then a high trans fatty acid diet and a high stearic acid diet for the second 5 
weeks. The serum CLA content was significantly increased by 30% for volunteers 
consuming the trans fatty acid diet compared with the dairy fat diet. However, during 
consumption of the stearic acid diet, the serum CLA decreased to about 50% of that during 
the dairy fat diet. The increase in serum lipid CLA following increased levels of trans fatty 
acids in the diet was attributed to the desaturation of trans-vaccenic acid (TVA) by A9-
desaturase (Corl and others 2001). 
Sources of CLA 
Major sources of CLA include dairy products and ruminant meats. Animal foods, 
especially foods from ruminant animals, contain more CLA than vegetable foods. Fats of 
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lamb, beef, or bovine milk contained ten times higher CLA (0.5 to 1%, CLA / lipid base, 
w/w) than pork, salmon, and egg yolk (Chin and others 1992). A synthetic CLA mixture 
consists of 30% cis-9, trans-11 CLA, 31% trans-10, cis-12 CLA, 24% cis-ll, trans-13 CLA, 
and 14% cis-8, trans-10 CLA (Christie and others 1997). Although CLA could be supplied in 
a synthetic form, dairy products provided a higher percent (>80%) of cis-9, trans-11 CLA, 
the more biologically active isomer (Chin and others 1992; Werner and others 1992). 
CLA in ruminant animal products 
Dairy products are principal dietary sources of CLA (Table 2). The CLA content in 
dairy products ranged from 2.9 to 11.3 mg / g fat (Riel and others 1963; Chin and others 
1992; Shantha and Decker 1993; Parodi 1996). However, Parodi (1994) found some dairy 
products from pasture-fed animals may have a CLA content as high as 30 mg / g fat. 
The CLA content in dairy products varies considerably. As early as 1963, Riel and 
others reported that the CLA content of milk often varies widely among herds due to dietary 
differences. CLA content of the unprocessed raw materials and the final fat content (Ha and 
others 1989), feed types and dietary regimens (Jiang and others 1996; Stanton and others 
1997; Kelly and others 1998; Boylston and others 2002), starter culture and microbial 
activity (Lin and others 1995; Jiang and others 1998; Kim and Liu 2002; Kishino and others 
2002), processing, packaging, and storage (Ha and others 1989; Werner and others 1992; Lin 
and others 1995; Shantha and others 1995; Lin and others 1998) are among the factors that 
contribute to variability in the CLA content of dairy products. These factors will be further 
discussed in Chapter 4. 
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Ruminant meats are also good dietary sources of CLA. Chin and others (1992) 
reported that lamb contained the highest amount of CLA (5.6 mg/g fat) in ruminants while 
veal had the lowest amount (2.7 mg/g fat). Fresh ground beef products ranged from 2.9 mg/g 
fat to 4.3 mg/g fat (Chin and others 1992). The effects of cooking methods and cooking 
temperatures on CLA content in beef steaks and ground beef were evaluated by Shantha and 
others (1994). Raw steaks contained CLA between 3.1 and 8.5 mg/g fat with 57 to 85% cis-9, 
trans-11 CLA. They also found freshly cooked rare (60°C) or well-done (80°C) ground beef 
patties contained 6.6 to 8.2 mg CLA / g fat. No significant differences in CLA occurred 
among cooking methods or degrees of doneness. 
CLA in non-ruminant animal products 
Non-ruminant animal products contain less CLA than do ruminant products. In non-
ruminant foods, turkey, chicken, pork, and egg yolk contained 2.5, 0.9, 0.6, and 0.6 mg CLA 
/g fat, respectively (Chin and others 1992). Only the CLA content of turkey is comparable 
with ruminant foods. Seafood contained 0.3 to 0.6 mg CLA / g fat (Chin and others 1992). 
The deposition of CLA in the tissues of non-ruminant animals has been attributed to dietary 
intake or conversion of LA to CLA by bacterial flora (Chin and others 1992). Intestinal 
microflora in the rat (Chin and others 1992) and other non-ruminants (Chin and others 1994) 
are able to isomerize LA to CLA. This result demonstrates that rumen bacteria are not the 
only source for the biosynthesis of CLA (Ip and others 1994). 
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Table 2. CLA content in dairy products 
Dairy products CLA content (mg / g fat) Reference 
Natural cheese 
Cheddar cheese 
Medium cheddar 
Sharp cheddar 
Sharp Cheddar 
Aged cheddar cheese 
Cottage cheese 
Cottage cheese 
Brick 
Reduced fat Swiss 
Blue 
Mozzarella 
Cream cheese 
Cougar Gold 
Processed Cheese 
Cheese whiz 
Cheez whiz™ 
Kraft cheese whiz 
American cheese 
American cheese 
Kraft squeeze cheese 
Cheese spread 
3.3 
4.1 
3.6 
4.6 
5.3 
4.5 
4.8 
7.1 
6.7 
5.7 
4.9 
3.6 
3.7 
2.1 
5.0 
6.4 
5.0 
4.26 
8.9 
4.02-4.26 
Ha and others 1989 
Chin and others 1992 
Chin and others 1992 
Lin and others 1995 
Werner and others 1992 
Chin and others 1992 
Lin and others 1995 
Chin and others 1992 
Chin and others 1992 
Chin and others 1992 
Chin and others 1992 
Ha and others 1989 
Lin and others 1995 
Lin and others 1995 
Ha and others 1989 
Chin and others 1992 
Shantha and others 1992 
Chin and others 1992 
Lin and others 1995 
Shantha and others 1992 
Lin and others 1995 
25 
Table 2. (Continued) 
Dairy products CLA content (mg / g fat) Reference 
Fluid milk products 
Evaporated milk 
Whole milk 
2% milk 
Fermented dairy products 
Plain yogurt 
Yogurt 
Butter milk 
Butter milk 
Sour cream 
Sour cream 
Custard style yogurt 
Low fat yogurt 
Frozen yogurt 
Nonfat yogurt 
3.4-6.4 
4.5 
4.1 
4.8 
3.8 
5.4 
4.7 
4.6 
4.1 
4.8 
4.4 
2.8 
1.7 
Lin and others 1995 
Lin and others 1995 
Lin and others 1995 
Chin and others 1992 
Lin and others 1995 
Chin and others 1992 
Lin and others 1995 
Chin and others 1992 
Lin and others 1995 
Chin and others 1992 
Chin and others 1992 
Chin and others 1992 
Chin and others 1992 
CLA in plant products 
Plant oils are not a major source of CLA in the typical human diet. In plant oils, such 
as canola, com, and olive oils, CLA contents range from 0.1 to 0.7 mg CLA / g fat, indicating 
the low CLA concentration of plant oils (Chin and others 1992). The distribution of 
individual CLA isomers in plant oils is also different from that in animal fat. Safflower oil 
contains the highest CLA content of plant oils, but the cis-9, trans-11 and trans-10, cis-12 
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CLA isomers account for 44% and 41% of the total CLA content, respectively. Due to the 
lack of LA isomerase from ruminai bacteria, LA doesn't specifically form cis-9, trans-11 
CLA. Therefore, the cis-9, trans-11 CLA isomer is not the predominant CLA isomer form in 
plant oils. Plant oils contain less cis-9, trans-11 CLA isomer and more trans-10, cis-12 CLA 
isomer than animal fat. 
Formation of CLA 
The mechanisms of CLA formation 
A major way for humans to increase their CLA intake and obtain the potential 
benefits of CLA is to consume CLA-enriched food products (Chamruspollert and Sell 1999). 
An understanding of the mechanism of CLA formation and factors, which affect CLA 
formation is needed to increase the CLA content in foods. 
Several mechanisms for the formation of CLA have been proposed. The 
biohydrogenation pathway involves the isomerization of linoleic and linolenic acids in the 
rumen to form CLA as shown in Figure 2 (Ha and others 1989; Harfoot and Hazlewood 
1997). The cis-9, trans-11 CLA isomer is identified as an intermediate in the 
biohydrogenation of LA by a LA isomerase from the bacterium, Butyrivibrio fibrisolvens, in 
the rumen (Kepler and others 1966). The cis-9, trans-11 CLA undergoes hydrogénation to 
form TVA. Further hydrogénation forms the end product, stearic acid. The concentration of 
the intermediate compounds, CLA and TVA, increases with a decrease in the rate of 
hydrogénation. The differences in the activity and amount of LA isomerase will affect the 
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activity of isomerization, and subsequently the CLA content of foods (Ha and others 1987; 
Chin and others 1992, 1993). 
LA (cis-9, cis-12-octadecadienoic acid) 
^ Isomerization 
CLA (cis-9, trans-11 -octadecadienoic acid) 
^ Hydrogénation 
trans vaccenic acid (trans-11- octadecenoic acid) 
^ Hydrogénation 
Stearic acid (octadecanoic acid) 
Fig. 2. The biohydrogenation pathway of LA in the rumen (Harfoot and Hazlewood 1997) 
Linoleic acid isomerase plays a key role in converting LA to CLA in the 
biohydrogenation pathway. LA isomerase is specific for free fatty acids with a cis-9, cis-12 
diene configuration (Kepler and Tove 1969; Chin and others 1994; Fellner and others 1997). 
The ability of enzyme extracts from dairy cultures (Lactobacillus acidophilus and 
Propionibacterium freudenreichii subsp. shermanii) to isomerize LA into CLA in vitro is 
attributed to the presence of LA isomerase (Lin and others 2002). With L. acidophilus, the 
content of CLA isomers, including trans-10, cis-12; cis-ll, trans-13; and cis-9, trans-11 
CLA, is greater at pH 5 than at pH 6, 7 and 8. These results suggest that pH 5 is optimal for 
the activity of LA isomerase. The pH values affect the activity of LA isomerase so that CLA 
formation is influenced. 
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Although biohydrogenation of LA has been shown as a major pathway to produce 
CLA in the rumen, CLA can be endogenously synthesized from ruminally derived trans-11 
C18:l by A9-desaturase in the mammary and adipose tissue of lactating cows (Griinari and 
Bauman 1999; Offer and others 1999; Corl and others 1998). An emulsified mixture of trans-
11 and trans-12 CI8:1 fatty acid (25 g / d) was continuously infused into the abomasums of 
cows. After 3 day infusion, the content of cis-9, trans-11 CLA increased by 55% compared 
to the pre-treatment value, but the content of trans-11 CI8:1 only showed minimal changes 
(Corl and others 1998). Corl and others (2001) found that infusion of partially hydrogenated 
vegetable oil, a source of trans-11 CI8:1, resulted in a 17% increase in cis-9, trans-11 CLA 
in the milk fat. However, the content of cis-9, trans-11 CLA was decreased by 60-65% with 
the addition of sterculic oil which specifically inhibits À9-desaturase. Since the desaturation 
of C14:0 by A9-desaturase also forms cis-9 C14:l, the formation of cis-9 C14:l was used to 
estimate A9-desaturase in the presence of sterculic oil. Using this correction factor, 
endogenous synthesis by A9-desaturase produced 78% of total cis-9, trans-11 CLA in milk 
fat and was the major source of cis-9, trans-11 CLA in milk fat of lactating cows. These 
results suggest that ruminai formation of trans-11 C18:l is important in developing feeding 
strategies to produce CLA-enriched milk. A feasible option to increase milk CLA content is 
to feed supplements containing trans-11 CI8:1 or dietary management of rumen 
biohydrogenation to enhance the formation of trans-11 C18:l (Griinari and Bauman 1999). 
Another mechanism of CLA formation, proposed by Ha and others (1989), involves a 
free radical reaction. The LA is first converted to a LA radical, and then the conjugated 
double bond system is formed with the addition of hydrogen. Heat treatment, atmospheric 
conditions, and hydrogen donors have been suggested to increase the formation of LA 
radicals and facilitate the conversion of LA radicals to CLA (Kosikowski 1982; Ha and 
others 1989; Shantha and others 1992; Garcia-Lopez and others 1994; Lin and others 1995). 
Several methods, such as organic synthesis, microbial fermentation, enzymatic 
isomerization, or genetic engineering / bioengineering have been used in commercial CLA 
production (Dunford 2001). As a traditional method, organic synthesis is highly capital 
intensive and produces isomeric mixture of CLAs. In the alkaline isomerization of LA, LA 
with cis-9, cis-12 double bonds is converted to cis-9, trans-11 and trans-10, cis-12 isomers. 
With the extension of time, the cis-9, trans-11 isomer is further isomerized to the trans-8, 
cis-10, and trans-10, cis-12 isomers, while the trans-10, cis-12 isomer forms cis-9, trans-11 
and cis-ll, frans-13 isomers (Dunford 2001). Bioengineering can produce CLA as the 
predominant fatty acid produced in plant oil (Dunford 2001). However, a long time is 
required to discover the desired genetic traits for developing bioengineered products and 
consumers may reject genetic modification products. Therefore, a viable alternative is to 
produce CLA by utilizing microorganisms containing LA isomerase. Biocatalysis by whole 
microorganisms or purified enzyme can produce CLA isomers with high specificity. 
Effects of dietary modification on CLA formation 
Individual differences between ruminai animals also contribute to differences in CLA 
formation. CLA content in milk has been shown to be affected by individual genetic 
regulation of rumen microflora (Moore and others 1993), individual differences in cow breed 
(Kelly and others 1998) and individual animal differences to variable diet treatments 
(Peterson and others 2002). These individual differences affect both rumen biohydrogenation 
and À9-desaturase activity in the mammary gland through the rumen microflora, rumen pH, 
the feeding behavior of the cow, the efficiency of incorporation of CLA into the milk or the 
conversion of TVA to CLA in the mammary gland. 
Several dietary strategies, such as the type of feed or dietary regimen, have been 
adopted to increase the CLA content of milk fat. The quantity and composition of animal 
feed affects the microbial population in the rumen. In ruminant tissue and milk, the content 
and isomer distribution of CLA are modulated through altering the lipid composition related 
to the formation of CLA or trans 18:1, the microbial activity associated with rumen 
biohydrogenation, and microbial population in the rumen (Vivani 1970). 
The feed plays an important role in increasing CLA content in milk fat. The CLA 
content during the summer is two or three times higher than during the winter (Jahreis and 
others 1997; Parodi 1999). In the summer, cows fed grass, rich in PUFA, produce a greater 
content of CLA and TVA in milk than do cows fed maize silage in winter. Pasture feeding 
produces a higher CLA content in the milk fat than control, which contains hay, corn silage, 
and concentrates (Jahreis and others 1997; Precht and Molkentin 1997; Kelly and others 
1998). There is a linearly positive relationship between the proportion of grazed grass from 
pasture in the diet of dairy cows and the CLA content of milk (Dhiman and others 1999). In 
the grazing pasture, linolenic acid is the major dietary unsaturated fatty acids. The 
biohydrogenation of linolenic acid is suggested to form CLA as an intermediate (Viviani 
1970). However, Harfoot and Hazlewood (1988) found linolenic acid biohydrogenation does 
not produce CLA as an intermediate, but produces trans-11 CI8:1 as one of final products. 
The endogenous synthesis of cis-9, trans-11 CLA occurs from trans-11 C18:l by A9-
desaturase (Griinari and others 1997). 
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The dietary regimen also affects CLA formation. Ecological feeding provides the 
cows grazing during summer season and silage (clover / alfalfa / grass silage) feeding in 
other seasons. Ecological feeding produced the highest CLA (0.8%) and TVA (2.67%) 
concentration in milk fat compared to indoor feeding with silage the whole year and pasture 
feeding during the summer (Jiang and others 1996). A positive linear correlation has been 
shown between cis-9, trans-11 CLA and TVA (r = 0.85) (Jahreis and others 1997). This 
conclusion is in agreement with results of Jiang and others (1996). This relationship suggests 
the first two steps in the biohydrogenation pathway (from C18:2 vis cis-9, trans-11- C18:2 to 
trans-11- CI8:1) are not rate-limiting. 
Milk CLA content is increased by the addition of dietary oil with a high PUFA 
content to the diet (Griinari and Bauman 1999; Dhiman and others 2000). Plant oils high in 
LA, such as sunflower (63% LA), soybean oil (50% LA) and corn oil (50% LA), efficiently 
increase milk CLA and trans-18:1 contents (McGuire and others 1996; Kelly and others 
1998; Dhiman and others 2000). These results may be explained because more LA substrate 
is available for LA isomerase to form CLA. Boylston and Beitz (2002) investigated the 
effects of feed supplementation on CLA and fatty acid composition of yogurt. The dietary 
supplementation (5% soy oil and 1% CLA) increased CLA contents of milk by 2.8 fold. 
Soybean oil supplementation decreased contents of saturated fatty acids and increased trans-
octadecenoic acids. 
Some disadvantages in the dietary supplementation of plant oils have been studied. 
Free oil, which contains a high content of PUFA, inhibits microbial (particularly cellulolytic) 
activity in the rumen (Jenkins 1993; Boyaval and others 1995; Jiang and others 1998; Lin 
and others 1999). As early as 1970, Vivani indicated the microbial population is inhibited by 
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long-chain fatty acids, in the free or esterified form, in the rumen. The inhibitory effect of 
fatty acids on the growth of bacteria is influenced by strains, concentration, and availability 
of fatty acids (Desmazeaud 1996). Some bacterial strains can produce variants that can resist 
inhibition by fatty acids. In general, intact seeds can effectively decrease the inhibition of 
fatty acids on bacteria compared to free oil. The higher amounts of plant oils and fish oil 
decreased ruminai metabolism. The addition of 2% fish oil or 2% soybean oil in the diet 
decreased milk fat percentages and yield, but increased milk CLA concentrations by 3.2 and 
1.9 fold, respectively (Dhiman and others 2000). 
An alternative method is to use intact seeds that are processed to provide unsaturated 
fatty acids for microbial biohydrogenation in the rumen. The partial replacement of com and 
soybean meal with soybean oil, linseed oil, raw cracked soybeans, and roasted cracked 
soybeans showed that the CLA content of cow's milk was increased when free oils, but not 
full-fat intact seeds, were added to the diet (Dhiman and others 1997). Therefore, the 
accessibility of lipids to the rumen microorganisms is important to enhance milk CLA 
content. Although linolenic acid is not a precursor of CLA in the rumen, feeding linseed oil, 
which is high in linolenic acid, greatly increased the production of rumen TVA, which can be 
used for CLA synthesis in the mammary gland (Chilliard and others 2000). However, other 
researchers found the addition of intact feeds to the diets enhanced CLA formation in milk 
fat. A high-rapeseed-supplemented diet and a low-rapeseed-supplemented diet increased 
CLA content from 4.8 mg CLA / g fat to 7.9 mg CLA / g fat and 5.2 mg CLA / g fat, 
respectively (Stanton and others 1997). There was a positive correlation between CLA and 
trans-11 C18:l. The contents of CLA in milk and cheese were increased 1.75 to 2.0 times by 
the inclusion of full-fat extruded cottonseed (ECS) and full-fat extruded soybeans (ESB), 
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respectively, compared to the inclusion of soybean meal (Dhiman and others 1999). The ESB 
and ECS make the oils more readily available for digestion. They also found the milk from 
the cows fed the ECS diet contained a higher content of C18:0 and a lower unsaturated fatty 
acid content (CI8:1, CI8:2 and CI8:3) than did cows fed ESB or soybean meal. The reasons 
may be due to the slightly lower fatty acid content in the ECS diet, different availability of 
fatty acids in the rumen, or differences in rumen biohydrogenation between the ECS and 
ESB diets. These results also suggested more complete rumen biohydrogenation for cows fed 
the ECS diet than for cows fed the ESB diet. Therefore, the milk CLA content can be 
enhanced by the addition of full fat ESB or ECS to the diets of dairy cows. 
The concentration of CLA in milk was greatly increased when cows were fed marine 
algae (Franklin and others 1999). Abu-Ghazaleh and others (2001) demonstrated that milk 
protein percentages and the contents of CLA, TVA, and omega-3 fatty acids in milk fat were 
increased when fish meal (0.5% fish oil from fish meal) completely replaced soybean meal in 
the diet of lactating cows. When a blend of fish meal and extruded soybeans (0.5% fish oil 
from fish meal and 2% soybean oil from extruded soybeans) was fed, the content of CLA and 
TVA was 91-109% greater than the additive effect of fish meal and extruded soybeans (Abu-
Ghazaleh and others 2002). Thus, fish oil increased the production of CLA and TVA by 
stimulating the conversion of linoleic and linolenic acid supplied from other dietary sources, 
such as extruded soybeans. Feeding lactating dairy cows a blend of 0.5% fish oil from fish 
meal and 2% soybean oil from extruded soybeans resulted in the greatest increase in CLA 
content (Abu-Ghazaleh and others 2002). 
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Effects of CLA as dietary lipid on milk fat content 
CLA incorporated into the diet has been shown to reduce the milk fat of cattle (Loor 
and Herbein 1998; Baumgard and others 1999; Hanson and others 1999). Loor and Herbein 
(1998) found that CLA concentration in blood plasma at 24 h after first abomasal infusion of 
200 g LCLA (1 part LA plus 1 part CLA) to cows was elevated five-fold compared to 
infusion with 200 g LA. The concentration of CLA in milk increased from 0.5 g /100 g total 
fatty acid to 3.3 g / 100 g total fatty acid when time was extended from 0 to 36 h in response 
to the LCLA infusion. LCLA contained 35 g cis-9, trans-11 CLA / 100 g total fatty acids and 
15 g trans-10, cis-12 CLA / 100 g total fatty acids. However, from 24 to 72 h, milk fat yield 
was 34% lower in response to LCLA than LA infusion due to decreased yields of short- and 
medium-chain fatty acids. Infusion with LCLA resulted in milk with twice the stearic acid 
content compared to infusion with LA. The oleic acid and arachidonic acid contents in milk 
declined with the increase of stearic acid content in response to LCLA infusion. These results 
suggested that CLA may be a potent inhibitor of de novo fatty acid synthesis and 
desaturation in mammary gland by directly inhibiting the enzymes involved, such as acetyl-
CoA carboxylase, fatty acid synthase, A9 stearoyl-CoA desaturase, and A6 desaturase (Loor 
and Herbein 1998). 
Recent studies have shown that trans-10, cis-12 CLA, but not cis-9, trans-11 CLA, 
contributes to a reduction in milk fat. Baumgard and others (1999) reported that 4 day 
abomasal infusion of trans-10, cis-12 CLA (10 g / d) resulted in a 44% decrease in milk fat 
yield, whereas infusing a similar amount of cis-9, trans-11 CLA had no effect. Further study 
was conducted to determine the dose effects of CLA on milk fat content. Milk fat yield was 
decreased by 25, 33, and 50% in response to 5-day abomasal infusion of 3.5, 7.0 and 14.0 g / 
day of trans-10, cis-12 CLA. The fatty acid ratios, such as Cu.o :Ci4:i,Ci6:o : Ci6:i,Cig:o : Ci8.i, 
increased with the infusion of high doses of trans-10, cis-12 CLA. This result demonstrated 
that higher doses of trans-10, cis-12 CLA (7.0 and 14.0 g / day) inhibited A9-desaturase 
activity so that milk fatty acid composition was changed, but the lower dose trans-10, cis-12 
CLA (3.5 g / day) had no effect (Baumgard and others 2001). Thus, dietary trans-10, cis-12 
CLA inhibited de novo fatty acid synthesis and desaturation in the mammary gland. 
However, the reduced desaturase was not a prerequisite to decrease milk fat yield. For 
example, a 25% reduction of milk fat was more equally distributed among short- and 
medium-chain fatty acids (28%), palmitic and palmitoleic acids (35%), and longer-chain 
fatty acids (36%). Therefore, a substantial reduction in uptake or utilization of preformed 
fatty acids was also a factor which contributed to the inhibition of milk fat synthesis. Trans­
it), cis-12 CLA has also been found to reduce the expression of fatty acid synthase in 
cultures of bovine mammary epithelial cells (Loor and Herbein 1998; Matitashvili and 
Bauman 2000). 
Effects of bacteria on CLA formation 
The effect of starter culture on CLA concentration has been widely studied in model 
systems with LA. Lin and others (1999) investigated the CLA-producing ability of six lactic 
cultures (Lactobacillus acidophilus, L. delbrueckii subsp. bulgaricus, L. delbrueckii subsp. 
lactis, Lactococcus lactis subsp. cremoris, L. lactis subsp. lactis, and Streptococcus 
salivarius subsp. thermophilus) in sterilized skim milk with added LA. The results showed 
LA addition is necessary to produce CLA. CLA was effectively produced at 1000 /xg / mL 
LA by all six bacteria during a 24-h incubation period. Under these conditions, L. 
acidophilus produced the maximal CLA content (105.5 fig CLA / mL). In the medium with 
no LA added, CLA concentration only reached 14.5-19.5 fig CLA / mL. Starter cultures did 
not influence CLA formation without the presence of LA. Ogawa and others (2001) 
demonstrated that washed cells of Lactobacillus acidophilus AKU 1137 under microaerobic 
conditions could produce CLA from LA. More than 95% of the added LA (5 mg / mL) was 
converted into CLA after a 4-day incubation with L. acidophilus AKU 1137. Linoleic acid 
was decomposed by washed cells of L. acidophilus AKU 1137 into an important hydroxy 
fatty acid, 10-hydroxy-c/s-12-octadecenoic acid. The accumulation of hydroxy fatty acid 
prior to CLA formation and its concomitant decrease with increased formation of CLA 
suggest that 10-hydroxy-cis-12-octadecenoic acid is also an intermediate of CLA production. 
This result demonstrated that the conversion of LA to CLA is not a one-step isomerization of 
a nonconjugated diene to a conjugated diene. Kishino and others (2002) found Lactobacillus 
plantarum AKU 1009a could produce high contents of CLA (3.88 mg/mL) in a nutrient 
medium with 0.06% (w/v) LA after screening 14 genera of lactic acid bacteria. At LA 
concentration below 0.06%, a lower CLA concentration (0.04 mg/mL) resulted. However, a 
higher content of LA (0.2%) inhibited the growth of the bacteria and decreased CLA 
production. Thus, optimal culture conditions are important to enhance CLA concentration. 
Kim and Liu (2002) reported that Lactococcus lactis 1-01 showed very high CLA-producing 
ability compared with the level present in normal milk fat when sunflower oil (SOL; 
containing 70% LA) was a substrate. The maximal CLA production resulted when L. lactis I-
01 cells were preincubated with the optimal concentration of SOL (0.1 g / L) in whole milk 
for 24 hr. The result indicated that esterified LA was an effective substrate for 
biohydrogenation by L. lactis 1-01 in vitro. Since lactic acid fermentation decreased pH, LA 
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isomerase was possibly inactivated by lower pH. Potassium phosphate buffer has been found 
to increase CLA concentration by preventing a pH drop. 
However, not all strains of commonly used dairy starter cultures are able to form 
CLA in vitro. Jiang and others (1998) evaluated 19 strains of lactococci, lactobacilli, 
streptococci, and propionibacteria in in vitro systems with free LA. None of the lactic acid 
bacteria and only Propionibacterium freudenreichii subsp. freudenreichii and P. 
freudenreichii subsp. shermanii demonstrated the ability to form CLA. 
The content of PUFA may possibly affect the CLA-producing ability of bacteria by 
inhibiting their growth. The inhibitory effect of free LA on the growth of 19 strains was 
studied (Jiang and others 1998). Most of the 19 strains of bacteria (lactococci, lactobacilli, 
streptococci, and propionibacteria) were inhibited upon inclusion of 25 (j,g / mL LA into the 
MRS broth. When washed-cell suspensions were incubated anaerobically with more than 350 
/xM LA or aerobically with 350 /xM LA, biohydrogenation and growth of Butyrivibrio 
fibrisolvens A38 were inhibited and the content of cis-9, trans-11 CLA was significantly 
increased. When the LA concentration reached 1,800 /wM, growth of bacteria was completely 
inhibited and no CLA formation was detected (Kim and others 2000). Thus, CLA 
accumulation was due to an inhibition of biohydrogenation. CLA was not a normal end-
product of growing cultures. Therefore, if microbial fermentation is used in large-scale 
production of CLA, the microorganisms' low tolerance to LA and the poor solubility of LA 
in water are the main concerns. However, Rainio and others (2001) indicated that the growth 
inhibitory effect of LA could be efficiently reduced when LA was dispersed in a sufficient 
concentration of polyoxyethylene sorbitan monooleate detergent. At an optimal LA: 
detergent ratio of 1:15 (w/w) in the whey-based growth medium, Propionibacterium 
freudenreichii subsp. shermanii JS could tolerate at least 1000 (j.g / mL LA and the 
conversion of LA to CLA reached 57% - 87%. This result suggests the microbial growth is a 
key factor to CLA formation in a whey-based system. 
The CLA-producing ability of bacteria can also be influenced by additives. Among 
six evaluated bacteria (Lactobacillus acidophilus, L. delbrueckii subsp. bulgaricus, L. 
delbrueckii subsp. lactis, Lactococcus lactis subsp. cremoris, L. lactis subsp. lactis, and S. 
salivarius subsp. thermophilus), the addition of 60 g / L sweeteners (sucrose, lactose, or 
fructose) and 10 g / L sodium chloride (NaCl) significantly decreased the cis-9, trans-11 
CLA content compared to the medium with no added sweeteners or NaCl (Lin 2000). Only 
L. lactis subsp. cremoris produced a higher CLA content than the control with the addition of 
fructose. In the presence of sucrose, the CLA formation was strongly inhibited due to the 
inversion of sucrose into glucose and fructose in an acid medium. The increased solute 
molecules assisted in lowering the water activity of the product so that growth of bacteria and 
CLA isomerizing activity of the cultures was lowered (Banwart 1989). Of all 6 lactic acid 
bacteria evaluated, L. acidophilus incubated in skim milk medium containing 60 g / L 
sweetener and 10 g / L NaCl under aerobic conditions produced the greatest CLA 
concentration for 24 hr incubation. In the fermented milk products, sweeteners or NaCl can 
affect the metabolism of starter cultures so that the CLA formation decreases. 
Effects of processing and storage on CLA formation 
The effect of processing on CLA concentration of dairy products has been widely 
investigated. CLA concentration has been shown to increase through processing from milk to 
processed cheese (Ha and others 1989; Shantha and others 1992; Shantha and Decker 1993). 
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The Cheddar-based processed cheeses have higher CLA concentration than unprocessed 
cheeses, except for American cheese (Dhiman and others 1999). Processing skim milk into 
nonfat yogurt and cream into butter increased the CLA concentration 1.2-fold and 1.3-fold, 
respectively (Shantha and others 1995). However, the CLA content in low-fat yogurt, low-fat 
and regular ice cream, sour cream, Mozzarella, Gouda and Cheddar cheeses did not show 
great differences when compared with raw milk. Werner and others (1992) reported that 
different starter cultures, processing conditions, and aging time showed only negligible 
effects on the total CLA content of Cheddar cheese but did influence the CLA isomer 
distribution. Chin and others (1992) also reported that CLA content was comparable in 
processed and natural cheeses, as well as unprocessed milk. 
Heat, presence of oxygen, additives, aging, and packaging have been suggested as 
important processing factors for CLA formation. Heat treatment and oxygen environment 
contributed to the enhanced CLA content of processed cheeses. In processed cheese, CLA 
formation increased at a higher processing temperature (80 °C) (Kanner and others 1987). 
Increasing the temperature when cheese was processed under nitrogen did not increase CLA 
content. When cheese was produced under normal atmospheric conditions, CLA content 
increased with an increase in temperature from 80 to 90 °C. However, heating temperatures 
of 70 or 85 °C did not show any effect on CLA content (Shantha and others 1992). In this 
study, lipid peroxides were not detected under either normal atmospheric conditions or 
nitrogen during processing. Therefore, the LA radicals formed during processing were 
primarily being converted to CLA instead of lipid peroxides. The atmospheric conditions 
resulted in a higher CLA content due to the greater formation of oxygen radicals which 
increased the formation of the LA radical. Under atmospheric conditions, higher 
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temperatures increased formation of LA and / or oxygen radicals to enhance CLA content. 
Garcia-Lopez and others (1994) also reported that CLA content increased from 9.5 mg / g of 
fat in the raw ingredients to 10.7 mg /g of fat in the processed cheese without apparent 
changes in the isomer distribution. The increase of CLA content was mainly attributed to the 
heat treatment. 
In the free radical oxidation pathway, a LA radical abstracts a proton from a hydrogen 
donor to produce CLA (Ha and others 1989). Shantha and Decker (1993) found that 
hydrogen donors (butylated hydroxytoluene, propyl gallate, cysteine, ascorbic acid) could 
increase the CLA content of processed cheeses. Propyl gallate, the most effective hydrogen 
donor, increased the total and cis-9, trans-11 CLA content of processed cheese by 1.59 and 
1.42-fold, respectively. As proton donors, cysteine and ascorbic acid gave similar increases 
in CLA concentration. However, the addition of BHA, tyrosine and lysine produced a lower 
CLA content than in processed cheese with no additives (Posati and others 1975; Hughes and 
others 1982). The antioxidant activity of BHA or tyrosine resulted in decomposition, 
isomerization, or saturation reactions which reduced the CLA content. Ferrous iron also 
significantly increased CLA concentration in processed cheeses by catalyzing free radical 
initiation. Compared to processed cheese with no added iron, addition of 500 ppm Fe2+ and 
Fe3+ / ascorbate increased total CLA 1.56- and 1.44-fold, respectively (Shantha and Decker 
1993). 
The effect of the protein component on the CLA concentration of dairy products has 
attracted much attention in the past couple of decades. Protein additives (sodium caseinate, 
sweet whey powder, and nonfat dry milk) have been found to increase the CLA content of 
processed cheeses (Caric and Kalab, 1987; Shantha and Decker 1993). Whey protein 
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contains relatively high contents of lactalbumin and lactoglobulin that can provide a 
hydrogen source and facilitate CLA formation (McDermott and others 1987). The most 
effective dairy additive was sodium caseinate, which increased CLA content 1.65-fold. 
Nonfat dry milk and whey powder increased CLA concentration 1.57- and 1.56-fold, 
respectively. Shantha and others (1992) showed CLA concentration in processed cheese was 
increased by 35% and 19% with a 6% increase of whey protein concentrate (WPC) and its 
low molecular weight (LMW) fraction, respectively. The CLA concentration was not 
increased by the high molecular weight (HMW) fraction of WPC. The enzymatic hydrolysis 
of proteins to LMW fractions also provided better hydrogen donors and facilitated CLA 
formation (Ha and others 1989; Shantha and Decker 1993). Since LMW in WPC plays a 
major role in the increase of CLA, whey ultrafiltration permeate can be used to enhance the 
content of CLA in processed cheese. 
Packaging type is another factor that affects CLA content in dairy products. Lin and 
others (1998) showed that CLA content in canned cheese (3.03 mg / g lipid) was significantly 
higher than in a vacuum pouch packed cheese (2.70 mg/g lipid) after 6 months of aging. 
The free radical oxidation mechanism may have contributed to the differences in CLA 
content. The interior of the canned cheese has more residual air than the pouch-packed 
cheese so that lipid oxidation, formation of allyl radicals, and protonation of the radicals are 
enhanced, resulting in increases in CLA formation. 
Other factors during dairy processing were also investigated to determine their effect 
on CLA content. Cheddar-type cheese aged for 3-month produced the highest CLA content 
(Lin and others 1999). However, when aging time was extended to more than 10 months, the 
CLA content decreased. Additional aging time resulted in further enzymatic hydrogénation 
of CLA to monoenoic and stearic acids (Hughes and others 1982). However, Werner and 
others (1992) showed aging did not cause changes in the CLA content of Cheddar-type 
cheeses. Only the CLA isomer distribution was affected by aging. Milling pH is also a factor 
which affected the CLA concentration of cheese during the aging period (Lin and others 
1998). Since lipolytic enzymes showed optimal activity at about pH 6.0 (Kitchen 1985), the 
milling pH of 5.9 resulted in increases in free fatty acids and produced higher CLA content in 
cheese than pH 5.5 and 5.7 after 1 month of aging. However, decomposition of CLA isomers 
occurred with longer aging periods. Therefore, the standard milling pH 5.7 showed maximal 
CLA value with 3 month of aging. 
Storage does not affect the CLA content in dairy products, such as low fat yogurt, 
regular yogurt, low fat and regular ice cream, sour cream, or cheeses (Shantha and others 
1995; Steinhart 1996). Boylston and Beitz (2002) demonstrated that no significant changes of 
CLA content or fatty acid composition in yogurt were observed after processing and storage 
for 7 days at 4°C. These results indicated that CLA is a stable component. Therefore, 
commercial dairy products are possible to provide health benefits to consumers. 
Analytical Methods for CLA Determination 
Dairy products are the predominant CLA sources. Since milk fat contains up to 400 
different fatty acids, which are different in chain length, degree of branching or unsaturation, 
geometric and positional configuration, there are many challenges in CLA analysis. 
Numerous spectroscopic and chromatographic methods have been developed for 
CLA analysis. Ultraviolet spectroscopy is an early method used to quantitate conjugated 
acids. CLA absorbs between 230 and 235 nm (Reil 1963; Dormandy and Wickens 1987). 
However, complex mixtures of fatty acids containing other conjugated fatty acids often 
interfere with the absorbance of CLA (Shantha and others 1993). This method is also limited 
because it can not separate all the individual CLA isomers. Therefore, a chromatographic 
method is needed to get more accurate results about the content of CLA isomers. Although 
liquid chromatography (LC) has been used in clinical studies to quantitate CLA, most CLA 
exist as cis-9, trans-11 CLA isomer in human body fluids and cervical cells (Iverson and 
others 1984; Green and others 1988). However, LC is not suitable to analyze CLA isomers in 
food because the CLA isomers are not separated. So gas chromatography (GC) is a common 
and convenient method for CLA analysis. 
GC is routinely used for the analysis of fatty acid due to its rapidity, high resolution 
and sensitivity. Fatty acids are often converted to fatty acid methyl esters (FAME) to increase 
volatility and nonpolarity. Lipid extraction is often the first step in CLA analysis. In total 
lipid extraction, solvent mixtures, such as chloroform / methanol /water, have been 
successfully used (Folch and others 1957; Blight and Dyer 1959). After extraction of lipid, 
GC with flame ionization detection has been widely used to analyze FAME. The preparation 
methods of FAME include acid-catalyzed methylation, base-catalyzed methylation, and basic 
and acidic reagents methods (AOCS Official Method 1990). 
Acid-catalyzed methylation has been extensively used to analyze conjugated dienes in 
milk and dairy products. The catalysts included boron trifluoride (BF3) in methanol (Ha and 
others 1989; Shantha and others 1992; Werner and others 1992; Jiang and others 1996), HC1 
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(Ha and others 1990; Ip and others 1991), and H2SO4 (Wolff 1994; Chardigny and others 
1996). Since acid-catalyzed methylation (HC1 and H2SO4) results in the isomerization of 
conjugated dienes, BF3 in methanol (BF3-MeOH) at room temperature has been recommended 
as an efficient method to reduce isomerization (Werner and others 1992; Jiang and others 
1996). The effects of methylation time (0.5-120 min) and temperature (20-100 °C) on CLA 
isomerization were studied (Werner and others 1992). The results demonstrated that 14% 
BF3-MeOH at room temperature (20 °C) for 30 min effectively methylated the CLA isomers 
and prevented intraisomerization of CLA isomers. However, the use of BFg-MeOH for 
methylation at high temperature (100 °C) for 10, 15 or 20 min resulted in increased 
intraisomerization of CLA isomers. 
Base-catalyzed methylation, such as NaOCHg or tetramethylguanidine, methylates the 
TGs but not free fatty acids (Aneja and Muethi 1991). The (trimethylsilyl) diazomethane can 
partially methyl ate free fatty acids. However, artifacts (trimethylsilyl CLA esters) and 
impurities (trimethylsilyl) are generated, which will interfere with the analysis of short-chain 
fatty acids by GC (Park and others 2001). Our samples contain a high content of free fatty 
acids and thus, are not suitable for base-catalyzed methylation. Therefore, the acid-catalyzed 
methylation was selected to analyze CLA. 
After methylation, analysis of FAME by GC using long capillary columns is a 
generally accepted method to separate and identify CLA isomers. The slight differences of 
columns, temperature program, and concentration have an impact on retention times of 
FAME. With conventional 25 m Carbowax columns, the methyl ester of cis-9, trans-11 18:2 
will elute in an area of the chromatogram free of potential contaminants. However, this 
column is unable to separate a wide range of geometrical and positional CLA isomers in 
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healthy food. Six CLA peaks were first detected in cheese using 60 m Supelcowax-10 fused 
silica capillary column (Ha and others 1989). Then, the GC resolution of CLA isomers was 
improved using 100 m CP-Sil88 WCOT fused silica capillary column, and 10 CLA isomers 
were separated (Kramer and others 1997). The 100 m highly polar cyanosilicone capillary 
columns have been shown to be the best GC column to analyze the closely related geometric 
and positional isomers of CLA. Shorter capillary columns (50 and 60 m) are sufficient to 
separate a mixture of two major CLA isomers (cis-9, trans-11 CLA and trans-10, cis-12 
CLA). However, they would not resolve the minor CLA isomers in most natural matrices 
(Kramer and others 2001). 
The identification of CLA is often based on comparison of retention times with 
standards and gas chromatography- mass spectrometry (GC-MS). Some CLA standards for 
cis-9, trans-11 CLA and trans-10, cis-12 CLA are available. GC-MS is also an effective 
pathway to identify and confirm CLA isomers. 
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ABSTRACT: The objective of this research was to study the effects of probiotic bacteria, 
lipid source, and fermentation time on the CLA content of a milk model system. The 
evaluation of 11 probiotic bacteria showed that they were able to produce CLA from linoleic 
acid in a model system containing hydrolyzed soy oil (1%) emulsified in milk, but not in 
model systems of unhydrolyzed soy oil (1%) emulsified in milk or 1% fat milk. 
Propionibacterium freudenreichii subsp. shermanii 56, P. freudenreichii subsp. shermanii 51 
and P. freudenreichii subsp. freudenreichii 23 demonstrated the greatest increase in CLA 
content. Propionibacterium. freudenreichii subsp. shermanii 51 produced the highest cis-9, 
trans-il CLA content and also produced the greatest increase in trans-10, cis-12 CLA 
content as fermentation time was increased from 24 to 48 h. The fermentation of probiotic 
bacteria for 24 h was often most effective in increasing CLA content. Viable counts of 
probiotic bacteria increased significantly from 0 to 24 h. These results demonstrated that the 
content of CLA during the fermentation was primarily dependent on the strain of probiotic 
bacteria and the lipid sources in the milk model system. This research suggests an efficient 
approach to produce CLA-enriched cultured dairy products. 
KEY WORDS: Conjugated linoleic acid, fermentation time, hydrolyzed soy oil, isomers, 
probiotic bacteria, cultured dairy products 
48 
CLA is a mixture of positional and geometric isomers of octadecadienoic acid with 
conjugated double bonds. This new functional component, found in dairy products, has been 
shown to have numerous nutritional benefits. The predominant isomer, cis-9, trans-11 CLA, 
has demonstrated anticarcinogenic activity in animal models (1). Trans-10, cis-12 CLA, 
another important isomer, inhibits fat synthesis and deposition in the adipose tissue (2). CLA 
also functions as an immune system modulator (3), antidiabetic agent (4), and 
antiatherosclerosis agent (5). These nutritional benefits associated with CLA have 
contributed to interest in enhancing the CLA content of foods and increasing the daily intake 
of consumers. 
Dairy products are the most important dietary sources of CLA. The CLA content of 
yogurts, cheeses, and other cultured dairy products ranges from 3.6 to 8.0 mg/g of lipid (6-8). 
Dahi, an Indian equivalent of yogurt, has a higher CLA content (26.5 mg/g lipid) than raw 
milk (5.5 mg/g lipid) (9). Variability in the CLA content of cheeses, yogurts, and other 
commercial dairy products depends on CLA content of raw milk, starter cultures, aging time 
and other processing treatments (6-8). 
A primary mechanism for the formation of CLA is the isomerization of linoleic and 
linolenic acids through a biohydrogenation process in the rumen. Kepler et al. (10) reported 
that an isomerase from Butyrivibrio fibrisolvens forms cis-9, trans-11 CLA as an 
intermediate. Further biohydrogenation reactions result in the formation of vaccenic acid 
(trans-W octadecenoic acid), elaidic acid (/rans-9-octadecenoic acid), and stearic acid 
(octadecanoic acid) (10, 11). A high concentration of linoleic acid or an aerobic condition 
inhibits the biohydrogenation reaction so that the CLA accumulates (12). 
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Another CLA production pathway is free radical oxidation of linoleic or linolenic 
acid during processing. Processing conditions, such as oxygen level, the addition of protein, 
elevated temperature and aging will affect CLA content. However, yogurts with higher fat 
content (1%, 2% and 3.25%) showed no significant changes in CLA content during 
processing (8). 
Several studies have focused on the ability of probiotic bacteria to form CLA in 
model systems. Six lactic cultures (Lactobacillus acidophilus, L. delbrueckii subsp. 
bulgaricus, L. delbrueckii subsp. lactis, Lactococcus lactis subsp. cremoris, Lc. lactis subsp. 
lactis, and Streptococcus salivarius subsp. thermophilus) demonstrated the ability to increase 
CLA content of model systems of sterilized skim milk and free linoleic acid (13). Kishino et 
al. (14) showed Lactobacillus plantarum produced CLA in a nutrient medium with 0.06% 
(wt/vol) linoleic acid. Kim and Liu (15) also reported that Lactococcus lactis 1-01 showed 
the highest ability among 13 lactic acid bacteria (lactobacilli and lactococci) to produce CLA 
in model systems with sunflower oil containing 70% esterified linoleic acid as the lipid 
source. However, of the 19 strains of lactococci, lactobacilli, streptococci, and 
propionibacteria evaluated, none of the lactic acid bacteria and only P. freudenreichii subsp. 
freudenreichii and P. freudenreichii subsp. shermanii demonstrated the ability to form CLA 
from free linoleic acid in in vitro systems (16). 
Probiotics are health-promoting bacteria with many potential benefits. These bacteria 
have been shown to preserve intestinal integrity, mediate the effects of inflammatory bowel 
diseases, and reduce the risk for colon, liver and breast cancers (17). 
The objective of this research was to study the effects of probiotic bacteria, lipid 
source, and fermentation time on CLA content in a milk model system consisting of 1% fat. 
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Hydrolyzed and unhydrolyzed soy oil were compared with milk fat to determine the effect of 
linoleic acid and FFA contents on CLA formation. A yogurt with probiotics and enhanced 
CLA content would bring the consumers great health benefits. The study would also provide 
valuable information for the biohydrogenation mechanism of CLA formation. 
EXPERIMENTAL PROCEDURES 
Treatments. Eleven different strains of probiotic and lactic acid bacteria were selected. 
Propionibacterium freudenreichii subsp. shermanii 56, P. freudenreichii subsp. shermanii 51 
and P. freudenreichii subsp. freudenreichii 23 were obtained from the National Collection of 
Food Bacteria (Reading, England). Lactobacillus acidophilus 74-2, L. casei 163, L. 
plantarum L2-1, L. rhamnosus, Enterococcus faecium M74, Pediococcus acidilactici and 
Bifidobacterium bifidum 420 were obtained from Danisco Cultor Inc. (Milwaukee, WI). 
Yogurt culture (Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus salivarius 
subsp. thermophilus 1:1) was obtained from Chr. Hansen's Inc. (Milwaukee, WI). Lactic 
acid bacteria were grown in Lactobacilli MRS broth (Difco, Detroit, MI) for 15 h at 37°C and 
the propionibacteria were grown in sodium lactate broth for 20-22 h at 32°C. The sodium 
lactate broth contained 1% (w/v) tryptic soy broth, 1% (w/v) yeast extract, and 1% (w/v) 
sodium lactate syrup. 
The model milk systems consisted of milk solids with different fat sources: 
hydrolyzed soy oil, unhydrolyzed soy oil, or milk fat at a 1% fat content. The hydrolyzed 
soy oil was prepared from soybean oil (Wesson, Conagra Grocery Products Company, Irvine, 
CA). Soybean oil (20-22 g) was hydrolyzed with ethanolic potassium hydroxide (60 mL of 3 
N potassium hydroxide in 3.3% ethanol) at 70°C with stirring for 24 h. The hydrolysis 
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reaction was neutralized with the addition of 12 N hydrochloric acid (16 mL) and refluxing at 
80°C for 3 h. Potassium hydroxide and hydrochloric acid were obtained from Fisher 
Scientific (Fair Lawn, NJ). The mixture was cooled to 50°C and the upper layer was passed 
through sodium sulfate to recover hydrolyzed soy oil. 
The soy oil (hydrolyzed and unhydrolyzed) was emulsified into a 10% acacia solution 
at a 1:1 (w/w) ratio to facilitate uniform incorporation of the oil into the milk. Each mixture 
(with hydrolyzed and unhydrolyzed oil) was homogenized into reconstituted non-fat dry milk 
(12% solids-not-fat; Hy-Vee Inc., West Des Moines, IA) to obtain a 1% fat content. A 1%-
fat milk (Swiss Valley Farm, Co., Davenport, IA) was used for the milk-fat treatment. The 
model milk systems were autoclaved at 121°C for 15 min, then cooled to room temperature 
(25°C). The target initial inoculation for all bacteria was 107 cfu/mL; actual inoculation 
levels ranged from 106 to 107 cfu/mL. Individual containers were prepared for each storage 
time to avoid disruption of the gel during fermentation. The milk systems were incubated at 
37°C for lactic acid bacteria or 32°C for propionibacteria as set gel. The model systems were 
sampled for lipid, microbiological and acidity analyses at 0, 24 and 48 h. 
Lipid analysis. Lipids were extracted from milk model systems using a modified 
Bligh and Dyer chloroform-methanol extraction method (6). The lipid extracts were 
hydrolyzed with 1 N NaOH in methanol at 100°C for 15 min and methylated with 14% boron 
tri fluoride in methanol (Alltech Associates Inc., Deerfield, IL) at room temperature for 30 
min to prevent intraisomerization of CLA isomers. Heptadecanoic acid (C,?:o, Sigma 
Chemical Co., St. Louis, MO) was used as an internal standard. FAME were analyzed on a 
gas chromatograph equipped with a FID (HP6890, Hewlett Packard Inc., Wilmington, DE) 
and separated using a CP-Sil 88 column (100 m x 0.25 mm ID; Chrompack, Middelburg, 
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Netherlands). The sample (1.0 fxL) was injected onto the column with a 5:1 split ratio. The 
temperature of the GC oven was held initially at 30°C for 5 min, increased to 125°C at 
10°C/min and held 1 min, increased to 145°C at 2°C/min, increased to 160°C at l°C/min and 
held 10 min, and finally increased to 190°C at 2°C/min and held for 10 min. The total run 
time was 75.5 min. The detector temperature was 225°C. CLA and FAME were identified 
and quantified by comparison with the retention time and peak areas of CLA standards 
(NuChek-Prep, Inc., Elysian, MN) and FA standards (Supelco, Inc., Bellefonte, PA). A gas 
chromatograph-mass spectrometer (Trio 1000, Fisons Instruments, Danvers, MA) with a 
quadrupole mass analyzer was used to confirm the identity of the FA. The GC conditions 
were the same as those of the chromatographic analysis. Mass spectrometer conditions were 
as follows: source electron energy at 70 eV, source electron current at 150 juA, ion source 
temperature at 220°C, interface temperature at 220°C, source ion repeller at 3.4 V, electron 
multiplier voltage at 600 V and scan range between 41 and 350 m/z. Mass spectra of the FA 
compounds were compared to a spectral library (NBS Library) for identification. 
Microbiological analysis. The microbial counts were determined by plating serial 
dilutions of suspensions on MRS agar for lactic acid bacteria and sodium lactate agar for 
propionibacteria. Buffered peptone water (2%, Difco, Detroit, MI) was sterilized and used 
for dilution blanks. The plates were incubated under anaerobic conditions at 37°C for 48 h 
(lactic acid bacteria) or 32°C for 72-96 h (propionibacteria). 
pH measurement. The pH of milk model systems was recorded using a digital pH 
meter (Fisher Scientific, Accumet Model AB15, Pittsburgh, PA). Decreases in pH were 
expressed as positive values relative to the initial pH. 
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Statistical analysis. The project was designed as a three-way factorial experiment 
with probiotic bacteria, lipid source and fermentation time as the main factors. The 
experiment was replicated two times using different sources of milk and oil. All analyses 
were conducted in duplicate. Experimental data were analyzed by using ANOVA (mixed 
linear model procedures) with Duncan's multiple range tests (SAS version 8.2, Cary, NC) 
with a significance level of 0.05 to determine the main effects and interactions between the 
main effects. 
RESULTS AND DISCUSSION 
The 11 different strains of bacteria were selected based on their current applications 
in dairy products, related literature research demonstrating the effectiveness of probiotic and 
lactic acid bacteria in CLA formation, and availability of the bacteria from commercial 
sources. Propionibacteria that have also been reported to enhance the CLA concentration in 
dairy products were also selected for our study. Conventional yogurt production uses L. 
delbrueckii subsp. bulgaricus and S. salivarius subsp. thermophilus, in a 1:1 ratio, as the 
starter cultures. The fermentation continues for 4 to 7 hr until a pH of 4.4 to 4.7 is reached. 
The bacteria evaluated in this study differ in their rate of acid production; thus, fermentation 
times of 24 and 48 hr were studied to allow the time necessary for the pH to decrease to the 
pH range of yogurt. Our study focused on a milk model system to identify bacteria with the 
ability to increase CLA content. 
CLA production in milk model systems. Hydrolyzed soy oil provided the best lipid 
source for all 11 probiotic bacteria to produce CLA (Table 1). This model system, containing 
FFA, resulted in significantly higher CLA contents than the model systems with esterified fatty 
acids. The formation of CLA was accompanied by an 11% decrease in the content of linoleic 
acid (data not shown). No significant differences in the content of CLA and other FA were 
noted in the model systems containing the unhydrolyzed soy oil emulsified in nonfat dry milk or 
milk fat. 
Linoleic acid isomerase, which is specific for free linoleic acid (18), catalyzes the 
formation of CLA from linoleic acid (19). Chin et al. (7) reported that linoleic acid 
isomerase isolated from B. fibrisolvens was able to isomerize linoleic acid of hydrolyzed 
safflower oil into CLA. Many model systems designed to evaluate the ability of bacteria to 
form CLA have used free linoleic acid as a lipid source (13, 14, 16). However, with 
sunflower oil (70% linoleic acid) as the lipid source, esterified linoleic acid was almost as 
effective as free linoleic acid as a substrate for the formation of CLA by L. lactis 1-01. The 
possible reason is L. lactis strains showed a high tolerance to sunflower oil and also that 
biohydrogenation is efficient as a detoxification system for unsaturated long-chain FA (15). 
Therefore, linoleic acid is the key precursor initiating the biohydrogenation process and 
promote the formation of CLA. 
The limiting factor in determining whether CLA formation will occur during the 
fermentation of dairy products by lactic acid and probiotic bacteria is the availability of free 
linoleic acid for the isomerization reaction. Linoleic acid is a relatively minor FA in cow's 
milk, accounting for approximately 2.4% of the total FA (19). The relatively high content of 
TAG (97.5%) and low content of FFA (0.027%) in cow's milk (19) suggests that the content 
of free linoleic acid in milk is inadequate to facilitate the formation of CLA during 
fermentation unless FFA are produced through the lipase activity of the bacteria. Soy oil 
contains a high concentration of esterified FFA, which are unable to enter the 
biohydrogenation pathway directly. Therefore, only the model system containing hydrolyzed 
soy oil had a high enough content of FFA to facilitate CLA formation through linoleic acid 
isomerase. 
The 11 lactic acid and probiotic bacteria showed CLA-producing ability only in the 
model system containing the hydrolyzed soy oil. Bacterial species did have a significant 
effect on CLA formation. The effect of bacterial species and fermentation time on the 
formation of the cis-9, trans-W and trans-10, cis-12 CLA isomers is presented for the milk 
model system with hydrolyzed soy oil as the lipid source (Table 2). 
Of the lactic acid and probiotic bacteria evaluated in this study, the propionibacteria 
demonstrated the greatest increase in CLA content. In particular, the total CLA content of the 
hydrolyzed oil model system fermented with P. freudenreichii subsp. shermanii 51 was 
significantly greater than the model system fermented with traditional yogurt cultures (Table 1). 
P. freudenreichii subsp. shermanii 51 showed the highest CLA-producing ability, with a cis-
9, trans-11 CLA content of 1.45 mg/g lipid at 24 h. This microorganism also produced 
significantly higher cis-9, trans-W and trans-10, cis-12 CLA levels at 48 h fermentation 
(Table 2). Propionibacterium freudenreichii subsp. shermanii 56 produced the highest trans-
10, cis-12 CLA content at 24 h fermentation. Other bacteria, such as P. freudenreichii subsp. 
freudenreichii 23, L. rhamnosus and P. acidilactici were not significantly different from the 
control (yogurt cultures) in their abilities to produce total CLA. 
The CLA-forming ability of different bacteria L. acidophilus, L. delbrueckii subsp. 
bulgaricus, L. delbrueckii subsp. lactis, L. lactis subsp. cremoris, L. lactis subsp. lactis, and 
Streptococcus salivarius subsp. thermophilus has been evaluated in several model systems. 
Among them, L. acidophilus was most effective in increasing the CLA content in a skim 
milk medium containing linoleic acid (13). Lactobacillus plantarum AKU 1009a efficiently 
produced CLA in a medium containing linoleic acid (14). Lactococcus lactis 1-01 showed 
high CLA-producing ability in sunflower oil containing esterified linoleic acid (15). Our 
results were consistent with those reported by Jiang et al. (16), in which P. freudenreichii 
subsp. freudenreichii and P. freudenreichii subsp. shermanii were better able to produce 
CLA from free linoleic acid than were the lactic acid bacteria in in vitro systems. In the 
biohydrogenation pathway for CLA formation, linoleic acid isomerase plays a key role in 
isomerizing linoleic acid into CLA. Linoleic acid isomerase, which catalyzes CLA 
formation, has been isolated from L. delbrueckii subsp. bulgaricus (13), B. fibrisolvens (8), L. 
acidophilus and P. freudenreichii subsp. shermanii (20). Thus, the linoleic acid isomerase 
activity of bacteria used in the production of cultured dairy products may contribute to 
differences in CLA formation. Starter cultures, because of the differences in their linoleic 
acid isomerase activity, have been identified as a factor that affects the CLA content of 
cultured dairy products. 
For most probiotic bacteria, increasing the fermentation time from 24 to 48 h did not 
increase CLA content. Propionibacterium. freudenreichii subsp. shermanii 51 produced the 
most cis-9, trans-W CLA (1.45 mg/g lipid) after 24 h fermentation; however, the CLA 
content remained unchanged as the fermentation time increased to 48 h. Only L. rhamnosus 
and P. acidilactici produced more cis-9, trans-11 CLA with prolonged fermentation. Three 
microorganisms, P. freudenreichii subsp. shermanii 51, L. acidophilus 74-2 and L. plantarum 
L2-1, produced more trans-10, cis-12 CLA as fermentation increased from 24 to 48 h. Lin et al. 
(13) showed prolonging fermentation time from 24 to 48 h did not enhance CLA formation for 
six lactic acid bacteria in skim milk system containing linoleic acid. Kim and Liu (15) reported 
that L. lactis 1-01 formed more CLA when fermentation time increased from 8 to 12 h. 
Therefore, the effect of fermentation time on the CLA content was dependent on the species of 
bacteria and isomer forms of CLA. In general, fermentation time had some impact on CLA 
formation but was not a key factor in determining the increase in CLA content. 
Growth and acid production of probiotic bacteria in the milk model systems. No two-
way or three-way interaction effects were found for probiotic bacteria, lipid source, and 
fermentation time on microbial growth or acid production. The relative growth rates and 
acid production of the probiotic bacteria were similar for each lipid source and fermentation 
time. 
The growth of bacteria in the model systems with the three different lipid sources 
increased sharply from the initial count (average 7.05 logio cfu/mL) during the first 24 h of 
fermentation. Although the increase in viable counts was slightly lower for the bacteria in 
the hydrolyzed soy oil model system (1.35 logio cfu/mL), the increase was not significantly 
different than for the unhydrolyzed soy oil and milk fat model systems (1.55 - 1.56 logio 
cfu/mL). The growth of some lactic acid bacteria (21) and propionibacteria (16) are inhibited 
by FFA. The inhibitory effect is dependent on the bacterial strains and the levels and 
availability of FA (22), with some bacteria strains being able to produce variants that can 
resist inhibition by FFA (23). In model systems, the addition of free linoleic acid (1 to 5 
mg/mL) had an antimicrobial effect on the growth of specific probiotic bacteria (13, 16). 
Propionibacteria {P. freudenreichii subsp. freudenreichii and P. freudenreichii subsp. 
shermanii) that were able to produce higher CLA levels were shown to be more susceptible 
to inhibition by free linoleic acid than propionibacteria (P. jensenii and P. thoenii), which 
produced lower CLA levels (16). 
Inhibitory FA must be sufficiently water soluble to reach an effective concentration in 
the aqueous solution and sufficiently hydrophobic to interact with hydrophobic proteins or 
lipids on the bacterial cell surface (23). In this study, the hydrolyzed oil, consisting of about 
47% free linoleic acid, was emulsified into an acacia solution prior to incorporating into the 
milk. The use of a hydrolyzed oil and acacia solution to disperse the FFA may contribute to 
the lack of a significant inhibitory effect of the FFA on microbial growth (24). 
The initial 24-h increases in the individual probiotic bacterial counts were 
significantly different; however, there were no significant increases in microbial counts with 
an increase in fermentation time from 24 to 48 h (Table 3). Lactobacillus rhamnosus showed 
the highest increase in bacterial growth. The increases in bacterial counts of E. faecium M74, 
L. casei 163, L. acidophilus 74-2 and P. freudenreichii subsp. shermanii 23 were not 
significantly different from that of L. rhamnosus. Bifidobacterium bifidum 420 showed the 
lowest change in bacterial counts. Many commercial probiotic yogurts also have been 
reported to have poor viability, particularly with respect to bifidobacterium strains (25), as 
was demonstrated in this study. Bifidobacteria are strict anaerobes and require bifidogenic 
factors for growth (25). Thus, the environment of the model milk systems does not appear to 
promote the growth of bifidobacteria. 
The presence of FFA in the hydrolyzed soy oil model system resulted in a lower 
initial pH (pH 5.85) than the model systems containing hydrolyzed soy oil (pH 6.37) or milk 
fat (pH 6.54). Acid production, as indicated by the decrease in pH during fermentation, was 
significantly affected by the lipid source of the model system. The decrease in pH of the 
hydrolyzed soy oil model system (0.71 pH units) was significantly less than in the model 
systems containing unhydrolyzed soy oil (1.17 pH units) or milk fat (1.28 pH units). 
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However, the final average pH of the model systems with the three different lipid sources 
was not significantly different. The inhibitory activity of FA was higher at pH 5 than at pH 6 
(21). The decreased acid production and reduced growth of the bacteria in the hydrolyzed 
soy oil model system was attributed to the lower initial pH of the model system and the 
presence of FFA. 
The pH of the milk model systems decreases through the production of lactic acid 
from lactose during fermentation. Table 4 shows data for the milk model system with 
hydrolyzed oil as the lipid source. There was a significantly greater decrease in pH when the 
fermentation time was extended from 24 to 48 h, indicating continued acid production by the 
bacteria although microbial counts did not change significantly. 
Table 4 also showed that for the milk model system with hydrolyzed oil, acid 
production was greatest for the lactobacillus species and the yogurt culture, resulting in pH 
ranging from 4.0-4.5. The model system with L. rhamnosus resulted in the lowest pH. On the 
other hand, B. bifidum 420 and the propionibacteria produced little acid during the 48-h 
fermentation period. The genus Lactobacillus produces lactic acid as its major fermentation 
product and is the preferred species to produce lactic acid. Lactobacillus acidophilus 74-2 is 
homofermentative, whereas L. casei 163, L. plantarum L2-1 and L. rhamnosus are 
facultatively heterofermentative. However, for propionibacteria, lactic acid production in 
fermentation processes can be an intermediate step in the production of other organic acids, 
such as propionic acid (26). In the model milk system with these lactic acid bacteria, hexoses 
are almost exclusively fermented to lactic acid, contributing to a rapid decrease in pH. Thus, 
differences in the production of acids by probiotic bacteria can contribute to the development 
of acid and reduction in pH during fermentation. 
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TABLE 1 
The Ability of Probiotic Bacteria to Produce Total CLAa(mg CLA/g lipid) in Three 1% Fat Milk 
Model Systems After 24 h Fermentation" 
Lipid sources 
Strain Hydrolyzed soy Unhydrolyzed Milk fat 
oil soy oil 
Propionibacterium freudenreichii subsp. 
shermanii 56 1.71 ± 0.78"= — + 
P. freudenreichii subsp. shermanii 51 2.21 ± 0.92" — + 
P. freudenreichii subsp. freudenreichii 23 1.32 ± 0.07'" — 
Lactobacillus acidophilus 74-2 1.06 ±0.14=" — 
— 
L. case; 163 1.13 ± 0.21cd — — 
L. plantarum L2-1 1.07 ± 0.28'" + — 
Enterococcus faecium M74 0.63 ± 0.00" — + 
L. rhamnosus 1.30 ± 0.57'" + — 
Pediococcus acidilactici 1.40 ± 0.42e" — + 
Yogurt cultures" 1.33 ±0.14'" — + 
Bifidobacterium bifidum 420 1.04 ± 0.35e" + — 
a
"+": 0 to 0.2 mg CLA/g lipid, CLA not detected. 
bMeans are duplicate analyses from two replications. Means within columns followed by the same 
superscript roman letters (b-d) are not significantly different (P > 0.05). CLA was not detected for any 
treatment at 0 h. 
CL delbrueckii subsp. bulgaricus and S. salivarius subsp. thermophilus (1:1). 
TABLE 2 
CLA Content (mg CLA/g lipid) of Hydrolyzed Soy Oil Model Systems Fermented with Lactic Acid and Probiotic Bacteria" 
cis- 9, I
 
O
 
£
 
trans-10, c/s-12 CLA 
Bacteria 24 h 48 h 24 h 48 h 
P. freudenreichii subsp. shermanii 56 0.88 ± 0.41ab x 0.91 ± 0.94ab x 0.29 ± 0.00a'x 0.18 ± 0.11ab,x 
P. freudenreichii subsp. shermanii 51 1.45 ± 0.69a,x 1.40 ± 0.77a,x 0.19 ± 0.09ab,x 0.25 ± O.O7a x 
P. freudenreichii subsp. freudenreichii 23 0.66 ± 0.00b,x 0.61 ± 0.00b'x 0.16 ± 0.07ab,x 0.20 ± 0.14ab,x 
L acidophilus 74-2 0.45 ± 0.14b,x 0.45 ± 0.00b x 0.19 ± 0.00ab'y 0.49 ± 0.00a,x 
L. casei 163 0.48 ± 0.00b,x 0.16 ± 0.05b,y 0.22 ± 0.18ab,x 0.16 ± 0.00ab,x 
L. plantarum L2-1 0.51 ±0.14b,x 0.46 ± 0.21b,x 0.16 ± 0.14ab,y 0.36 ± O.O7a x 
E. faecium M74 0.63 ± 0.00b,x 0.73 ± 0.07b,x ND 0.05 ± 0.01c x 
L. rhamnosus 0.31 ± 0.22b y 0.67 ± 0.07b x 0.16 ± 0.07ab x 0.06 ± 0.01c,x 
P. acidilactici 0.30 ± 0.17b'y 0.85 ± 0.07b,x 0.12 ± 0.08b,x 0.06 ± 0.00c,x 
Yogurt cultures6 0.71 ± 0.07b,x 0.59 ± 0.07b,x 0.19 ± 0.06ab,x 0.15 ± 0.00ab-x 
B. bifidum 420 0.46 ± 0.15b x 0.57 ± 0.00b,x 0.20 ± 0.14ab'x 0.04 ± 0.02c x 
3 Means are duplicate analyses from two replications. Means within columns followed by the same superscript (a-c) roman letters are not 
significantly different (P > 0.05). For each CLA isomer, means within rows followed by the same superscript (x-y) roman letters are not 
significantly different (P > 0.05). CLA was not detected for any treatment at 0 h. 
bL. delbrueckii subsp. bulgaricus and S. salivarius subsp. thermophilus (1:1). 
TABLE 3 
Growth of Lactic Acid and Probiotic Bacteria in Hydrolyzed Oil Model System After 24 and 48 h Fermentation8 
Actual viable counts (logm cfu/mL) Increase in viable counts (login cfu/mL) 
Bacteria Oh 24 h 48 h 24 h 48 h 
P. freudenreichii subsp. shermanii 56 7.30 ±0.91" " 8.25 ± 0.88abc'x 8.26 ± 0.86abc,x 0.95 ± 0.03abc x 0.96 ± 0.05cd x 
P. freudenreichii subsp. shermanii 51 7.66 ±0.18" 8.36 ± 0.76abx 8.75 ± 0.08abx 0.70±0.57bcx 1.09 ± 0.10bcd x 
P. freudenreichii subsp. 
freudenreichii 23 5.37 ± 1,93
bx 6.90 ±1.27'x 6.46 ± 2.06c x 1.53±0.66abcx 1.09 ±0.13bcd x 
L. acidophilus 74-2 6.93 ± 0.00abz 8.37 ± 0.20ab,y 8.8 ± 0.11abx 1.44±0.20abcx 1.87 ± 0.11abc x 
L. casei 163 7.28 ± 0.44" y 9.29 ± 0.02a-x 9.59 ± 0.04a'x 2.01 ±0.42a'x 2.31 ± 0.40" 
L. plantarum L2-1 7.45 ± 0.0#* 8.61 ±0.13abx 8.73 ± 0.08ab,x 1.16 ± 0.06abc x 1.28 ± 0.16bcd'x 
E. faeciem M74 7.10 ± 0.06ay 8.79 ± 0.06abx 9.02 ± 0.42abx 1.69 ± 0.00abc'x 1.92 ± 0.35abc x 
L. rhamnosus 7.14 ± 0.36a,y 9.02 ± 0.18ab'x 9.15 ± 0.00ab,x 1.88 ± 0.54ab x 2.01 ± 0.36abx 
P. acidilactici 7.34 ± 0.17ay 8.63 ± 0.04abx 8.54 ± 0.16abx 1.29 ± 0.21 abc'x 1.20 ±0.01^ 
Yogurt cultures6 6.96 ± 0.59abx 7.94 ± 0.54abc x 8.07 ± 0.06abc x 0.98 ± 1.12abc x 1.11 ±0.65bcd'x 
B. bifidum 420 7.03 ± 0.04ax 7.64 ± 0.57bc x 7.53 ± 1.17bc x 0.61 ± 0,53cx 0.50 ± 0.77d x 
"Means are duplicate analyses from two replications. Means within columns followed by the same superscript roman letters (a-d) are not significantly 
different (P > 0.05). Means within rows followed by the same superscript roman letters (x-z) are not significantly different (P > 0.05). 
b L. delbrueckii subsp. bulgaricus and S. salivarius subsp. (hemophilus (1:1). 
TABLE 4 
Acid Production of Lactic Acid and Probiotic Bacteria in Hydrolyzed Oil Model System After 24 and 48 h Fermentation8 
Actual pH values Decrease in pH values 
Bacteria Oh 24 h 48 h 24 h 48 h 
P. freudenreichii subsp. shermanii 
56 5.93 ± 0.06" 5.51 ± 0.40
abx 5.36 ± 0.41" 0.42 ± 0.34obx 0.57 ± 0.35de x 
P. freudenreichii subsp. shermanii 
51 5.93 ±0.01" 5.52 ± 0.42
abx 5.16 ± 0.10cd,x 0.41 ± 0.40ab,x 0.77 ± 0.08d,x 
P. freudenreichii subsp. 
freudenreichii 23 5.93 ±0.01" 5.92 ± 0.08" 5.89 ±0.01" 0.01±0.00
bx 0.04 ± 0.00f x 
L. acidophilus 74-2 5.77 ± 0.06" 5.26 ± 0.21ab x 4.28 ± 0.18f y 0.51 ± 0.15aby 1.49 ±0.11ab x 
L. casei 163 5.77 ± 0.08" 4.92 ± 0.06b,y 4.24 ± 0.14f z 0.85 ± 0.02ab x 1.53 ± 0.23ab x 
L. plantarum L2-1 5.70 ± 0.04" 5.22 ± 0.04aby 4.76 ± 0.00de z 0.48 ± 0.07ab y 0.94 ± 0.04cd x 
E. faeciem M74 5.89 ± 0.09" 5.35 ± 0.09aby 5.11 ±0.15cdy 0.54 ± 0.18abx 0.78 ± 0.24dx 
L. rhamnosus 5.80 ± 0.22" 4.80 ± 0.26b,y 3.84 ± 0.15gz 1.00 ± 0.48" 1.96 ± O.O7a x 
P. acidilactici 5.93 ± 0.06" 5.57 ± 0.02aby 5.45 ± 0.06^ y 0.36 ± 0.04abx 0.48 ± 0.12def'x 
Yogurt cultures6 5.83 ±0.21" 4.92 ± 0.78b,x 4.48 ± 0.27efx 0.91 ± 0.99abx 1.35 ± 0.48bc x 
B. bifidum 420 5.88 ± 0.04" 5.87 ±0.01" 5.81 ±0.01abx 0.01±0.02bx 0.07 ± 0.04ef x 
aMeans are duplicate analyses from two replications. Means within columns followed by the same superscript roman letters (a-g) are not significantly 
different (P > 0.05). Means within rows followed by the same superscript roman letters (x-z) are not significantly different (P > 0.05). 
b L. delbrueckii subsp. bulgaricus and S. salivarius subsp. thermophilus(1:1). 
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ABSTRACT: The effect of probiotic bacteria and other processing parameters on the 
formation of CLA in yogurt was determined. Four probiotic bacteria, Lactobacillus 
rhamnosus, Propionibacterium freudenreichii subsp. shermanii 56, P. freudenreichii subsp. 
shermanii 51 and P. freudenreichii subsp. freudenreichii 23, were evaluated alone or in 
conjunction with traditional yogurt cultures (Lactobacillus delbrueckii subsp. bulgaricus and 
Streptococcus salivarius subsp. thermophilus). The yogurt used hydrolyzed soy oil as the 
lipid source and was incubated at 45 °C. L. rhamnosus, either alone or in conjunction with 
yogurt culture, resulted in the highest content of CLA. The yogurt processed with the 
propionibacteria alone had a lower CLA content than the control yogurt. The growth of 
propionibacteria was inhibited at 45 °C. The addition of yogurt cultures or rennet greatly 
increased the microbial counts and CLA content of yogurts processed with propionibacteria 
at 45 °C. Inoculation concentration of L. rhamnosus and yogurt cultures had no significant 
effect on CLA content of yogurts. The yogurt produced by L. rhamnosus in conjunction with 
yogurt culture with 107 CFU/mL total inoculation level resulted in the high content of CLA. 
In general, the CLA content and microbial counts of yogurts were stable over a 14-day 
storage time at 4 °C. 
Keywords: conjugated linoleic acid, yogurt, probiotic bacteria, propionibacteria, microbial 
counts 
69 
Introduction 
Conjugated linoleic acid (CLA) refers to a mixture of conjugated positional and 
geometric isomers of linoleic acid. The nutritional benefits of CLA have been demonstrated 
in vitro and in animal studies. The predominant CLA isomer, cis-9, trans-11 octadecadienoic 
acid, functions as an anticarcinogen in animal models (Ip and others 1994; Corl and others 
2001). Another important CLA isomer, trans-10, cis-12 octadecadienoic acid, can reduce 
body fat in mice (Park and others 1997). Other health benefits of CLA include roles as an 
antiatherogenic agent (Nicolosi and others 1997), an antidiabetic agent (Houseknecht and 
others 1998), immune system modulator (Hayek and others 1999), and body weight protector 
(Chin and others 1994). These results have exciting implications for improved human health 
and development of functional food products. 
Among all food products, ruminant products, especially dairy products, are the richest 
sources of CLA (Chin and others 1992; Shantha and others 1994). Fermented dairy products 
often contain higher levels of CLA than nonfermented milk (Aneja and Murthi 1990; 
Shantha and others 1995; Jiang and others 1998; Kim and Liu 2002). The CLA content of 
cultured dairy products is influenced by the CLA content of the raw milk, starter cultures, 
aging time and other processing and production conditions (Ha and others 1989; Chin and 
others 1992; Lin and others 1995, 1999a; Shantha and others 1995). 
The biohydrogenation pathway has been proposed to be a major mechanism for CLA 
formation. The cis-9, trans-11 CLA isomer is identified as an intermediate in the 
biohydrogenation of linoleic acid by a linoleic acid isomerase from the bacterium, 
Butyrivibrio fibrisolvens, in the rumen (Kepler and others 1966). The cis-9, trans-11 CLA 
undergoes hydrogénation to form trans-vaccenic acid. Further hydrogénation forms the end 
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product, stearic acid. Linoleic acid isomerase activity of rumen microorganisms and probiotic 
bacteria, including Butyrivibrio fibrisolvens, Lactobacillus acidophilus and P. freudenreichii 
subsp. shermanii, contributes to CLA formation (Kepler and others 1966; Lin and others 2002). 
Free linoleic acid is the primary substrate for linoleic acid isomerase and the 
biohydrogenation pathway of rumen bacteria (Kepler and Tove 1969). 
Probiotic bacteria, including lactococci, lactobacilli, streptococci and propionibacteria, 
contributed to the formation of CLA in model systems with linoleic acid as the substrate (Lin 
and others 1999b; Jiang and others 1998; Kishino and others 2002). Our previous 
investigation identified several probiotic bacteria that produced increased levels of CLA in a 
model system containing hydrolyzed soy oil emulsified in non-fat dry milk. These bacteria 
included Lactobacillus rhamnosus, Propionibacterium freudenreichii subsp. shermanii 56, P. 
freudenreichii subsp. shermanii 51 and P. freudenreichii subsp. freudenreichii 23 (Xu and 
others 2004). 
The objective of this research was to develop a CLA-enriched yogurt product with 
probiotic bacteria with the demonstrated ability to form CLA (Xu and others 2004). Yogurt 
was produced with hydrolyzed soy oil, 4 probiotic bacteria (Lactobacillus rhamnosus, 
Propionibacterium freudenreichii subsp. shermanii 56, P. freudenreichii subsp. shermanii 51 
and P. freudenreichii subsp. freudenreichii 23), and traditional yogurt culture under typical 
yogurt processing conditions. The effect of incubation temperature, hydrolysis of casein and 
inoculation concentration on CLA formation was also determined. 
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Materials and Methods 
Bacteria 
Lactobacillus rhamnosus, P. freudenreichii subsp. shermanii 56, P. freudenreichii 
subsp. shermanii 51, and P. freudenreichii subsp. freudenreichii 23 were selected to evaluate 
CLA formation of yogurt produced with the selected bacteria alone or in conjunction with 
traditional yogurt cultures (1:1 ratio of L. delbrueckii subsp. bulgaricus and S. salivarius subsp. 
thermophïlus-, YC-180 (YC), Chr. Hansen, Milwaukee, WI). The combination of probiotic 
bacteria and the yogurt culture was at a 1:1 ratio. L. rhamnosus (LB) was obtained from 
Danisco Cultor Inc. (Milwaukee, WI). Propionibacterium freudenreichii subsp. freudenreichii 
23 (PFF-23), P. freudenreichii subsp. shermanii 56 (PFS-56) and P. freudenreichii subsp. 
shermanii 51 (PFS-51) were obtained from Dr. Bonita Glatz's Collection (Iowa State University, 
Ames, IA) and stored at - 80 °C. Lactic acid bacteria were activated in Lactobacilli MRS 
broth (Difco, Detroit, MI) for 15 h at 37 °C and the propionibacteria were activated in sodium 
lactate broth for 20-22 h at 32 °C. The sodium lactate broth contained 1 % (w/v) tryptic soy 
broth (Becton Dickinson and Company, Cockeysville, MD), 1% (w/v) yeast extract (Becton 
Dickinson and Company, Sparks, MD), and 1% (w/v) sodium lactate syrup (Fisher Scientific, 
Fair Lawn, NJ). 
Processing of yogurt with hydrolyzed soy oil 
Soybean oil (Wesson, Conagra Grocery Products Company, Irvine, CA) was 
chemically hydrolyzed to increase the content of free fatty acids and emulsified into a 10% 
acacia solution at a 1:1 (w/w) ratio (Xu and others 2004). The mixture was homogenized into 
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skim milk (Hy-Vee Inc., West Des Moines, IA) to produce a 1% fat content. The milk solids-
not-fat content was adjusted to 12% through the addition of non-fat dry milk (Hy-Vee Inc., 
West Des Moines, IA). The mixture was heated at 85 °C for 30 min, cooled to 45 °C, and 
inoculated with probiotic bacteria and/or yogurt cultures and incubated as designated in the 
following experiments. 
Experiment 1: Effect of probiotic bacteria on CLA formation of yogurt 
The milk samples were inoculated at 107 CFU/mL for single culture (YC, LB, PFS-
56, PFS-51 and PFF-23) or 2 x 107 CFU/mL for the combination of YC with probiotic 
bacteria (YC+LB, YC+PFS-56, YC+PFS-51, and YC+PFF-23) at a 1:1 ratio. The samples 
were incubated at 45 °C until a pH of 4.4 was reached, and then was transferred to 4 °C. 
Following transfer, the yogurt was sampled at 1, 7, and 14 days for microbiological and lipid 
analyses. 
Experiment 2: Effect of temperature and protein hydrolysis on growth and 
CLA-producing ability of propionibacteria 
Rennet tablet 0.80 g (Redco Foods Inc., Windsor, CT) was added to 1 L skim milk 
(Hy-Vee Inc., West Des Moines, IA) containing hydrolyzed soy oil (1% fat) and incubated 
for 40 min at 25 °C. The milk with added rennet was inoculated with PFS-51 at 107 CFU/mL. 
Milk (without added rennet) was inoculated with YC, PFS-51 at 107 CFU/mL and the 
combination of YC with PFS-51 at 2 x 107 CFU/mL. The samples were incubated at 32 or 45 
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°C until a pH of 4.4 was reached, and then were transferred to 4 °C. After 1-day storage, the 
yogurts were sampled for microbiological and lipid analyses. 
Experiment 3: Effect of initial concentration of starter culture on CLA 
formation of yogurt 
Yogurt culture, LB, and the mixed cultures of YC and LB, were inoculated at 106, 107, 
108 CFU/mL into skim milk (Hy-Vee Inc., West Des Moines, IA) containing hydrolyzed soy 
oil (1% fat). The combination of L. rhamnosus and the yogurt culture was at a 1:1 ratio. The 
bacteria treatment was expressed as follows: For example, 7YC means yogurt culture with 
inoculation concentration 107 CFU/mL; 8(YC+LB) means the mixture of yogurt culture and 
L. rhamnosus with inoculation concentration about 2 x 108 CFU/mL. The yogurt was 
incubated at 45 °C until a pH of 4.4 was reached, and then was transferred to 4 °C. Following 
transfer, the yogurt was sampled at 1,7, and 14 days for microbiological and lipid analyses. 
Lipid analysis 
Lipids were extracted from yogurt model systems using a modified Bligh and Dyer 
chloroform-methanol extraction method (Lin and others 1995). With heptadecanoic acid 
(Ci7:o, Sigma Chemical Co., St. Louis, MO) as an internal standard, the lipid extracts were 
hydrolyzed with 1 N NaOH in methanol at 100 °C for 15 min and methylated with 14% 
boron tri fluoride in methanol (Alltech Associates Inc., Deerfield, IL) at room temperature (25 
°C) for 30 min to prevent intraisomerization of CLA isomers (Werner and others 1992). The 
fatty acid methyl esters (FAME) were analyzed on a gas chromatograph equipped with a 
74 
flame ionization detector (Model HP6890, Hewlett Packard Inc., Wilmington, DE) and 
separated using a CP-Sil88 column (100 m x 0.25 mm ID; Chrompack, Middelburg, 
Netherlands). The column pressure was set at 275.8 KPa with a helium flow rate of 6.2 
mL/min. The sample (1.0 fiL) was injected onto the column with a 5:1 split ratio. The 
temperature of the GC oven was held initially at 30 °C for 5 min, increased to 125 °C at 10 
°C/min and held 1 min, increased to 145 °C at 2 °C/min, increased to 160 °C at 1 °C/min and 
held 10 min, and finally increased to 190 °C at 2 °C/min and held for 10 min. The total run 
time was 75.5 min. The detector temperature was 225 °C. Flow rates of detector gases were 
air at 400 mL/min, hydrogen at 30 mL/min and nitrogen (make-up gas) at 18 mL/min. CLA 
and fatty acid methyl esters were identified and quantified by comparison with the retention 
time and peak area of CLA standards (NuChek-Prep, Inc., Elysian, MN) and fatty acid 
standards (Supelco, Inc., Bellefonte, PA). 
A GC-MS (Trio 1000, Fisons Instruments, Danvers, MA) with a quadrupole mass 
analyzer was used to confirm the identify of the fatty acid methyl esters. The GC conditions 
were the same as those of the chromatographic analysis. The mass spectrometer conditions 
were set as follows: source electron energy at 70 eV, source electron current at 150 juA, ion 
source temperature at 220 °C, interface temperature at 220 °C, source ion repeller at 3.4 V, 
electron multiplier voltage at 600 V and scan range between 41 and 350 m/z. Mass spectra 
of the fatty acid methyl esters were compared to a spectral library (NBS Library) for 
identification. 
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Microbiological analysis 
The microbial count was determined using Lactobacilli MRS agar (Difco, Sparks, 
MD, USA) for lactic acid bacteria and sodium lactate agar for propionibacteria. The sodium 
lactate agar consisted of sodium lactate broth and 2% (w/v) agar. Samples were diluted in 
buffered peptone water (2%, Difco, Detroit, MI) and plated in duplicate using the surface 
plating method. The plates were incubated under anaerobic conditions at 37 °C for 48 h 
(lactic acid bacteria) or 32 °C for 72-96 h (propionibacteria). The mixed cultures of lactic 
acid bacteria and propionibacteria were plated on the two different agars. The total counts for 
mixed cultures were calculated by determining the counts of individual bacteria on two agars. 
Statistical analysis 
Experiment 1 was designed as a 2-way factorial experiment with bacterial culture and 
storage time as the main factors. Each treatment was replicated three times. Experiment 2 
was designed as a 2-way factorial experiment with bacterial treatment and incubation 
temperature as the main factors. Each treatment was replicated two times. Experiment 3 was 
designed as a 3-way factorial experiment with inoculation level, bacterial culture and storage 
time as the main factors. Each treatment was replicated three times. The experimental data 
were analyzed using analysis of variance (mixed linear model procedures) and Duncan 
multiple range test (SAS version 8.2, Cary, NC, 2004) with a significance level of 0.05. 
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Results and Discussion 
Effect of probiotic bacteria on CLA formation 
The milk was inoculated with either probiotic bacteria alone or probiotic bacteria in 
conjunction with the yogurt cultures. The microbial counts of the yogurt cultures, L. rhamnosus, 
and the probiotic bacteria with the yogurt cultures ranged from 8.94 to 9.30 logio CFU/mL 
following storage at 4 °C for 1 day (Table 1). Total microbial counts decreased slightly with 
storage, with the counts for these treatments at 14 days ranging from 8.48 to 9.13 logio CFU/mL. 
These treatments (yogurt cultures, L. rhamnosus, and the probiotic bacteria with the yogurt 
cultures) had no significant effect on microbial counts after 14 days of storage at 4 °C. For most 
bacterial treatments, storage time did not have a significant effect on microbial count. Only the 
combination of L. rhamnosus and yogurt culture showed a significant decrease between 1 and 7 
days. 
The microbial counts of the yogurts processed with the 3 propionibacteria (PFF-23, 
PFS-51 and PFS-56) were significantly lower than those processed with lactic acid bacteria. 
Microbial counts in the yogurts processed with the propionibacteria alone decreased to 6.14 to 
6.72 logio CFU/mL after 1 day of storage. Storage time did not have a significant effect on the 
microbial counts of the bacteria (Table 1). The growth of propionibacteria in the yogurts with 
propionibacteria and yogurt cultures was significantly higher than in yogurts with only 
propionibacteria, suggesting that the growth of propionibacteria was enhanced in the presence 
of the yogurt culture. 
Condon and others (2001) indicated that growth of propionibacteria in a whey-based 
model system was stimulated by lactic acid bacteria, such as L. helveticus, L. bulgaricus and 
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S. thermophilics. The extent of the stimulation was dependent on the particular pair of 
propionibacteria and lactic acid bacteria. The most effective combination was L. delbrueckii 
subsp. lactis LL51 and P. freudenreichii P23. L. delbrueckii subsp. lactis LL51 increased the 
growth rates of P. freudenreichii P23 from 1.19 to 2.04 logio CFU/mL. The metabolic 
products of the lactic acid bacteria, such as peptides, lactic acid and carbon dioxide, 
facilitated the growth of propionibacteria (Baer and Ryba 1998; Condon and others 2001). 
Propionibacteria contain peptidases capable of supplying the cell with all essential amino 
acids (Vorobjeva 1999). So peptides are an important substrate for the physiological activity 
of propionibacteria. Lactate is a preferred substrate for the growth of propionibacteria, while 
carbon dioxide forms a more anaerobic environment to facilitate the growth of 
propionibacteria. 
Previous research demonstrated the ability of probiotic bacteria to produce CLA from 
linoleic acid only in the model system containing the hydrolyzed soy oil emulsified in non-fat 
dry milk. Of 11 probiotic bacteria evaluated, 3 propionibacteria (P. freudenreichii subsp. 
shermanii 56, P. freudenreichii subsp. shermanii 51 and P. freudenreichii subsp. 
freudenreichii 23) and L. rhamnosus demonstrated the greatest increase in CLA content (Xu 
and others 2004). These 4 bacteria were selected to evaluate CLA formation of yogurt 
produced with the selected bacteria alone or in conjunction with traditional yogurt cultures. 
In this study, the combination of most probiotic bacteria with the yogurt cultures 
produced slightly higher contents of cis-9, trans-11 and trans-10, cis-12 CLA than yogurt 
culture alone after 14 days of storage (Table 2). The yogurt processed with the combination of 
yogurt culture and L. rhamnosus showed significantly higher cis-9, trans-11 and trans-10, cis-
12 CLA content than the yogurt processed with yogurt culture alone. The yogurt processed with 
the propionibacteria (PFF-23, PFS-51 and PFS-56) alone was lower in cis-9, trans-11 and 
trans-10, cis-12 CLA content than the yogurt processed with the propionibacteria and yogurt 
culture together. Although the propionibacteria alone were shown to be effective in the 
formation of CLA in a model system (Xu and others 2004), they were less effective in the 
formation of CLA in a yogurt system. In the model system, the incubation temperature was 
optimized for the growth of the propionibacteria (32 °C). However, the fermentation 
temperature typically used for yogurt processing and used in this study (45 °C) significantly 
inhibited the growth of propionibacteria. Thus, the combination of yogurt culture and 
propionibacteria improved microbial counts of propionibacteria and increased CLA formation in 
the yogurt product compared to propionibacteria alone. 
The ability of probiotic bacteria to form CLA has been demonstrated in model systems. 
Propionibacterium freudenreichii subsp. freudenreichii and P. freudenreichii subsp. 
shermanii in in vitro systems with 500 or 750 jwg/mL free linoleic acid (Jiang and others 
1998), L. acidophilus in skim milk medium with 1000 pig/mL linoleic acid (Lin and others 
1999b), L. lactis 1-01 in whole milk medium with 100 or 200 jug/mL sunflower oil containing 
70% linoleic acid (Kim and Liu 2002), and L. plantarum AKU 1009A in a nutrient medium 
with 0.06% (wt/vol) linoleic acid (Kishino and others 2002), have been shown to 
significantly increase the CLA content of model systems. Lin (2003) demonstrated the 
mixed cultures comprising yogurt culture and Lactobacillus acidophilus with 0.1% linoleic 
acid addition significantly improved cis-9, trans-11 CLA content in non-fat set yogurt. 
However, few studies have evaluated CLA-forming ability when probiotic bacteria were 
combined with conventional yogurt cultures. 
In general, storage time did not have a significant effect on CLA content of yogurts. 
For most bacterial cultures including yogurt culture, L. rhamnosus, P. freudenreichii subsp. 
shermanii 51 and the combination of yogurt culture and probiotic bacteria, the CLA 
concentration is relatively stable during storage. In previous research, the CLA content of 
yogurt has been shown to be stable during storage periods of 7 days (Boylston and Beitz 
2002) and 6 weeks (Shantha and others 1995). Thus, the CLA-forming ability of the starter 
cultures rather than storage had an impact on the CLA content of yogurt. 
Effect of temperature and casein hydrolysis on propionibacteria 
Compared to our previous study (Xu and others 2004), Experiment 1 showed that the 
microbial growth and CLA formation in yogurt processed with propionibacteria was reduced. 
A major difference between the two studies was the incubation temperature of the milk 
samples. The optimal growth temperature for propionibacteria is 32 °C, but the yogurt 
production is generally conducted at 45 °C. In Experiment 1, the increased microbial growth 
and CLA formation by the propionibacteria in the presence of the yogurt cultures was 
attributed to the metabolic activity of the lactic acid bacteria. Experiment 2 was designed to 
further study the effect of temperature and casein hydrolysis on microbial growth and CLA 
formation. 
The effect of temperature and casein hydrolysis on the microbial growth of 
propionibacteria was shown in Table 3. At 32 °C, there was no significant difference in the 
microbial counts of the yogurt culture, PFS-51 with or without rennet addition, and PFS-51 
with the yogurt cultures. However, the yogurt produced with PFS-51 showed significantly 
lower microbial counts than other treatments at 45 °C. Although 45 °C was not the optimal 
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temperature for the growth of propionibacteria, our results demonstrated that the addition of 
yogurt cultures or rennet in the milk with PFS-51 greatly increased the microbial counts of 
the yogurt. The production of peptides by the proteolytic systems of yogurt cultures has been 
proposed to stimulate the growth of propionibacteria (Piveteau and others 2002). The 
increased growth of the propionibacteria at 45 °C was attributed to casein hydrolysis by the 
addition of rennet or yogurt cultures. The hydrolysis of casein through the addition of rennet 
or proteolytic activity of yogurt cultures increased the microbial counts of propionibacteria in 
the yogurt incubated at 45 °C. 
Table 4 showed the effect of temperature and protein hydrolysis on CLA production. 
At 32 °C, the yogurt processed by PFS-51 with or without rennet, and the combination of 
PFS-51 and yogurt cultures showed similar cis-9, trans-11 and trans-10, cis-12 CLA contents. 
The 3 yogurts processed with PFS-51 had a significantly higher content of cis-9, trans-11 
CLA than yogurt processed with the yogurt cultures. However, the yogurt processed with 
PFS-51 alone was significantly lower in cis-9, trans-11 CLA content than the other 
treatments incubated at 45 °C. Therefore, casein hydrolysis significantly increased CLA 
formation for PFS-51 under the non-optimal incubation temperature of 45 °C. This is an 
effective approach for enhancement of CLA content in actual yogurt production. Among the 
yogurts produced with PFS-51, the addition of yogurt cultures or rennet both greatly 
increased the CLA content because they both contributed to protein hydrolysis. The casein 
hydrolysis, either through the metabolic activity of the yogurt cultures or rennet activity, 
stimulated the growth of the propionibacteria when the incubation temperature is not ideal 
for propionibacteria. This result also partially explained why propionibacteria in conjunction 
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with yogurt cultures could overcome the non-optimal temperature effect and produce a 
significantly higher CLA content than with propionibacteria alone. 
Effect of initial concentration of YC and LB on microbial counts and CLA 
formation of yogurt 
The linoleic acid isomerase activity of bacteria contributes to the CLA formation in 
dairy products. Our study used hydrolyzed soy oil as the lipid source, but only a small 
percentage (about 11%) of the available linoleic acid was isomerized to CLA. It appears the 
linoleic acid isomerase rather than the substrate is the limiting factor in the CLA formation. 
Increasing the initial bacteria level might increase the amount of linoleic acid isomerase 
available. However, most current studies do not show strict control of the inoculation levels 
and monitor viability of the starter culture during storage time. Therefore, a further study was 
conducted to evaluate the effect of initial concentration, composition of starter culture, and 
storage time on the CLA content and microbial growth of yogurts. 
Growth of starter cultures in yogurts 
The milk was inoculated with YC, LB, or LB in conjunction with the YC. The 
microbial cell counts of cultures at the 3 inoculation levels (106, 107, 108 CFU/mL) 
throughout the 14-day storage period were evaluated (Table 5). The microbial counts 
increased significantly at 4 °C for 1 day storage with the counts reaching 8.24 to 9.21 logio 
CFU/mL. Yogurt culture with initial level 108 CFU/mL was an exception. When the 
inoculation level of yogurt cultures was as high as 108 CFU/mL, no significant growth was 
observed from 0 to 14 d. Although bacteria viability decreased with time, no significant 
difference in microbial counts was found from 1 d to 14 d at 4 °C. Only 8LB showed a 
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significant decrease in microbial counts at 14 days. Thus, the yogurt showed a stable level of 
microbial cells during 14-day cold storage. 
The effect of inoculation levels on the growth of bacteria were reported in 3 groups -
YC, LB, the combination of YC and LB. For every group, the initial bacteria levels had no 
significant impact on the microbial counts during 14-day storage at 4 °C. The increased initial 
concentration of bacteria did not affect the microbial counts of bacteria in yogurts over a 14-
day storage time. Only 8YC showed lower microbial counts. When the inoculation level 
were 10* or 107 CFU/mL, microbial counts of yogurts didn't show any difference for YC, LB 
or LB in conjunction with YC. However, the growth of 8YC was significantly lower than 
8(YC+LB) at 14 d. In general, initial inoculation level did not affect microbial counts of 
yogurts. 
Since the health benefits of probiotic bacteria depend on microbial cells ingested, it is 
important to maintain certain levels of microbial bacteria in probiotic foods. The bacterial 
counts exceeded the suggested minimum count (107 CFU/mL) which is needed to affect the 
gut environment and bring health benefits to people (Vinderola and Reinheimer 1999). 
Therefore, the determination of microbial numbers of microorganisms in the yogurt product 
is very necessary. Our results showed all yogurt samples showed high microbial lactic 
bacteria counts (> 108 CFU/mL) at the end of the 14 d storage period. 
CLA content of yogurts 
Our previous research demonstrated LB, either alone or in conjunction with yogurt 
culture, resulted in the greatest formation of CLA (Table 2). The CLA formation was further 
evaluated in the yogurt produced with YC, LB, or the combination of YC and LB with 
different inoculation levels. In general, the starter culture and inoculation level had no 
significant effect on cis-9, trans-11 CLA content and trans-10, cis-12 CLA content during 
storage at 4 °C (Table 6). Of the bacteria treatments evaluated, 6YC and 6(YC+LB) resulted 
in the highest content of cis-9, trans-11 CLA at 14-day storage, but not significantly different 
from other bacterial treatments. Therefore, higher inoculation level did not contribute to a 
higher CLA content. The partial reason might be attributed to similar microbial counts from 
1 to 14 d. Lin (2003) reported inoculation of mixed yogurt culture and Lactobacillus 
acidophilus with 0.1% linoleic acid addition significantly increased cis-9, trans-11 CLA 
content compared with individual yogurt culture and Lactobacillus acidophilus. The 
incorporation effect of yogurt culture and another probiotic bacterium in enhancing CLA 
content is dependent on different bacteria strains. 
In this study, no significant difference in cis-9, trans-11 CLA level was found with 
the extension of storage time. However, the content of trans-10, cis-12 CLA increased with 
storage time at 4 °C (Table 6). Especially for 6LB, 8LB and 7(YC+LB), significant increases 
were observed between 1 and 14 days of storage. The yogurt produced with 8LB showed 2.3 
fold increase of trans-10, cis-12 CLA content at 14 days. Although no significant difference 
in trans-10, cis-12 CLA levels was found at the end of 14 d storage for all bacteria treatments 
and inoculation levels, the yogurt processed with 6LB or 8LB demonstrated lower CLA 
formation at 1 and 7 days. Only when the storage time extended, CLA content greatly 
increased. Therefore, storage time affected the content of trans-10, cis-12 CLA of yogurts. 
The differences among bacteria treatments in the CLA-forming ability could be decreased 
with the extension of storage time. 
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Conclusions 
Probiotc bacteria can be added during processing to enhance the health-promoting 
potential of yogurt. Yogurt culture in conjunction with probiotic bacteria provided an effective 
approach to produce similar CLA content as control yogurt. The yogurt processed with the 
propionibacteria alone resulted in lower CLA content compared to the control yogurt. However, 
the hydrolysis of casein through either the addition of yogurt cultures or rennet increased CLA 
formation at incubation temperature not optimal for growth of propionibacteria. Inoculation 
level did not have a significant effect on microbial growth or CLA formation. Bacterial 
treatment, incubation temperature, casein hydrolysis, and inoculation level, were shown to affect 
CLA formation. Further research is needed to evaluate the quality attributes of CLA-enriched 
yogurt products. The effect of probiotic bacteria on flavor, texture and acidity of yogurts should 
be studied. These quality attributes must be considered in the development of functional foods 
with enhanced CLA content. 
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Table 1- Effect of storage time on total microbial counts3 of yogurts processed with 
probiotic bacteria 
Strain Microbial counts (log10 CFU/mL)" 
1 Day 7 Day 14 Day 
YC 8.98a,x 8.98a,x 8.80a,x 
YC+LB 9.21 a,x 8.63ab,y 8.73a,y 
LB 8.94a,x 8.71 ab,x 8.64a,x 
YC+PFS-51 9.30a,x 8.88a,x 9.13a,x 
PFS-51 6.14b,x 6.52c,x 5.75b,x 
YC+PFS-56 9.22a,x 8.85a,x 8.48a,x 
PFS-56 6.72b,x 7.13bc,x 5.99b,x 
YC+PFF-23 9.28a,x 8.83a,x 8.71 a,x 
PFF-23 6.38b,x 6.68c,x 5.85b,x 
"Means in the same column followed by the same letter (a-c) are not significantly different (p > 0.05) for bacterial treatment 
effect. Means in the same row followed by the same letter (x-y) are not significantly different (p > 0.05) for storage effect. 
Means are triplicate analyses of three replications. 
"inoculation level of every treatment (0 day) was 6.86-7.99 log,0 CFU/mL. 
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Table 2- The effect of incorporation of probiotic bacteria with yogurt culture on the 
cis-9, tran&-~\ 1 and trans-10, cis-12 CLA content3 of yogurts 
CLA content" (mg/g lipid) 
cis-9, trans-11 CLA frans-10,c/s-12 CLA 
Strain 1 Day 7 Day 14 Day 1 Day 7 Day 14 Day 
YC 0.45a,x 0.42ab,x 0.57bc,x 0.27ab,x 0.27abc,x 0.38cd,x 
YC+LB 
LB 
0.33a,x 
0.44a,x 
0.39ab,x 
0.44ab,x 
0.97a,x 
0.73ab,x 
0.33ab,x 
0.32ab,x 
0.31 ab,x 
0.34ab,x 
0.71 a,x 
O.BBab.x 
YC+PFF-23 
PFF-23 
0.53a,x 
0.22b,x 
0.57a,x 
0.23b,x 
0.65abc,x 
0.39cd,x 
0.32ab,x 
0.13b,x 
0.39a,x 
0.11c,x 
0.41 abc,x 
0.16d,x 
YC+PFS-56 
PFS-56 
0.57a,x 
0.19b,x 
0.51 ab,x 
0.21 b,x 
0.63abc,x 
0.25d,x 
0.43a,x 
0.11b,xy 
0.38a,x 
0.09c,y 
0.50abc,x 
0.12d,x 
YC+PFS-51 
PFS-51 
0.42a,x 
0.17b,x 
0.29ab,x 
0.21 b,x 
O.BOabc.x 
0.24d,x 
0.18b,x 
0.12b,x 
0.31 ab,x 
0.13bc,x 
0.41 abc,x 
0.11d,x 
"Means in the same column followed by the same letters (a-d) are not significantly different (p > 0.05) for bacterial treatment 
effect. Means in the same row followed by the same letters (x-y) are not significantly different (p > 0.05) for storage effect. 
Means are averages of three replications. 
bCLA was not detected for any treatment at 0 day. 
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Table 3- Effect of temperature on the microbial counts3 of yogurts after 1-day storage 
Microbial counts" (log10CFU/ml) 
Treatment 32 °C 45 °C 
YC 8.08a,x 8.83a,x 
PFS-51 8.83a,x 7.18b,y 
PFS-51+YC 9.21 a,x 9.23a,x 
PFS-51+REC 9.08a,x 8.66a,x 
"Means in the same column followed by the same letters (a-b) are not significantly different (p > 0.05) for treatment effect. 
Means in the same row followed by the same letters (x-y) are not significantly different (p > 0.05) for temperature effect. Means 
are averages of two replications. 
"inoculation level of every treatment (0 day) was 7.61-7.93 log™ CFU/ml. 
"PFS-51 + RE refers to PFS-51 inoculated in the milk with the addition of rennet. 
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Table 4- Effect of temperature on the CLA content3 of yogurts after 1-day storage 
CLA content" (mg/g lipid) 
cis-9, trans-11 CLA frans-10, c/s-12 CLA 
Treatment 32 °C 45 °C 32 °C 45 °C 
YC 0.63b,x 0.72a,x 0.22a,x 0.25a.x 
PFS-51 1.95a,x 0.26b,y 0.26a,x 0.18a,x 
PFS-51+YC 2.57a,x 0.59a,y 0.26a,x 0.17a,x 
PFS-51+REC 1.87a,x 0.73a,y 0.15a,x 0.23a,x 
"Means in the same column followed by the same letters (a-b) are not significantly different (p > 0.05) for treatment effect. For 
cis-9, frans-11 CLA or frans-10, c/s-12 CLA, means in the same row followed by the same letters (x-y) are not significantly 
different (p > 0.05) for temperature effect. Means are averages of two replications. 
bCLA was not detected for any treatment at 0 day. 
"PFS-51 + RE refes to PFS-51 inoculated in the milk with the addition of rennet. 
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Table 5- Effect of bacterial cultures and storage time on microbial counts3 of yogurts 
Microbial counts (log10CFU/mL) 
Strain Inoculation level 0 Day 1 Day 7 Day 14 Day 
YC 6 6.16c,y 9.17a,x 8.43a,x B.ôOab.x 
7 7.16b,y 8.84a,x 8.81 a,x 8.96a,x 
8 8.16a,x 8.24b,x 8.46a,x 8.11b,x 
LB 6 6.47c,y 9.20a,x 9.10a,x 8.99a,x 
7 7.47b,y 8.99a,x 9.03a,x 8.78ab,x 
8 8.47a,y 9.10a,x 9.05a,x 8.74ab,y 
YC+LB 6 6.66c,z 9.05a,x 8.90a,xy 8.36ab,y 
7 7.66b,z 9.21 a,x 8.82a,xy 8.56ab,y 
8 8.66a,y 9.14a,x 8.91 a,x 8.97a,x 
° Means in the same column followed by the same letter (a-c) are not significantly different (p > 0.05) for bacterial treatment 
effect. Means in the same row followed by the same letter (x-z) are not significantly different (p > 0.05) for storage effect. 
Means are triplicate analyses of three replications. 
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Table 6- Effect of bacterial cultures and storage time on the content of cis-9, trans-11 
and trans-10, cis-12 CLA content3 of yogurts 
CLA content (mg/g lipid) 
cis-9, trans-11 CLA frans-10, c/s-12 CLA 
Strain Inoculation 1 Day 7 Day 14 Day 1 Day 7 Day 14 Day 
level 
YC 6 0.42a,x 0.62a,x 0.58a,x 0.26a,x 0.28ab,x 0.42a,x 
7 0.43a,x 0.39b,x 0.48a,x 0.1 Bab,x 0.27ab,x 0.39a,x 
8 0.46a,x 0.30b,x 0.36a,x 0.23ab,x 0.24ab,x 0.26a,x 
LB 6 0.33a,x 0.27b,x 0.27a,x 0.13b,y 0.15b,y 0.24a,x 
7 0.38a,x 0.42b,x 0.43a,x 0.19ab,x 0.35a,x 0.33a,x 
0.24ab,x 
8 0.54a,x 0.35b,x 0.50a,x 0.12b,y y 0.40a,x 
YC+LB 6 0.47a,x 0.39b,x 0.52a,x 0.20ab,x 0.33a,x 0.38a,x 
7 0.34a,x 0.38b,x 0.47a,x 0.17ab,y 0.31 a,xy 0.45a,x 
8 0.50a,x 0.45ab,x 0.46a,x 0.17ab,x 0.38a,x 0.38a,x 
" Means in the same column followed by the same letter (a-b) are not significantly different (p > 0.05) for bacterial treatment 
effect. Means in the same row followed by the same letter (x-y) are not significantly different (p > 0.05) for each CLA isomer for 
storage effect. Means are averages of three replications. 
bCLA was not detected for any treatment at 0 day. 
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ABSTRACT: Quality attributes of yogurt with probiotic bacteria incorporated to increase 
CLA content were evaluated. Four probiotic bacteria, Lactobacillus rhamnosus, 
Propionibacterium freudenreichii subsp. shermanii 56, P. freudenreichii subsp. shermanii 51 
and P. freudenreichii subsp. freudenreichii 23, were evaluated alone or in conjunction with 
traditional yogurt cultures (Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus 
salivarius subsp. thermophilus). Hydrolyzed soy oil was the lipid source in the yogurt. The 
yogurt processed with probiotic bacteria, L. rhamnosus or yogurt cultures in conjunction with 
probiotic bacteria demonstrated similar acidity, texture and flavor as the control yogurt 
produced with yogurt cultures. The yogurt processed with the propionibacteria alone showed 
different texture and flavor attributes than the control yogurt. In general, the quality 
characteristics of yogurts were stable over a 14-day storage time at 4 °C. The effect of 
inoculation concentration (106, 107, and 108 CFU/mL) of L. rhamnosus, yogurt cultures, and 
mixed cultures of yogurt cultures and L. rhamnosus on quality attributes of yogurt was 
determined. Inoculation concentration of L. rhamnosus and yogurt cultures had no significant 
effect on texture, but affected acidity and volatile flavor compounds of yogurts. The yogurt 
produced by L. rhamnosus in conjunction with yogurt culture with 107 CFU/mL total 
inoculation level resulted in desirable quality characteristics. This research demonstrated that 
CLA-enriched yogurt products with L. rhamnosus or the combination of probiotic bacteria 
and yogurt cultures showed acceptable quality attributes. 
Keywords: conjugated linoliec acid (CLA), yogurt, flavor, inoculation concentration, 
texture, acidity 
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Introduction 
Functional foods are considered to elicit benefits to health and well-being or to have 
disease-preventing properties beyond their inherent nutritional value. Recent growth in the 
functional foods market stems from the identification of physiologically active components 
in foods. Functional dairy products with probiotic bacteria and enhanced contents of 
conjugated linoleic acid (CLA) have attracted much attention. 
Probiotics could actively enhance the health of consumers by improving the intestinal 
microbial balance. The positive effects associated with probiotics include anti-tumor activity, 
cholesterol reduction, protection against gastroenteritis, improvement of lactose tolerance 
and stimulation of the immune system through non-pathogenic means (Rastall and others 
2000). Lactic acid bacteria (Lactobacilli, Streptococci, Lactococci, Bifidobacteria) and 
propionibacteria constitute promising probiotic bacteria used in dairy food industries. 
Conjugated linoleic acid, a mixture of conjugated positional and geometric isomers of 
linoleic acid, has demonstrated unique biological activities in in vitro and animal studies, 
including an anticarcinogenic agent (Corl and others 2001), body-fat reducer (Park and 
others 1997), antiatherogenic agent (Nicolosi and others 1997), antidiabetic agent 
(Houseknech and others 1998), immune system modulator (Hayek and others 1999), and 
body weight protector (Chin and others 1994). 
Several studies have shown that probiotic bacteria can form CLA in model systems. 
Six lactic acid bacteria (Lactobacillus acidophilus, L. delbrueckii subsp. bulgaricus, L. 
delbrueckii subsp. lactis, Lactococcus lactis subsp. cremoris, L. lactis subsp. lactis, and 
Streptococcus salivarius subsp. thermophilus) (Lin and others 1999), Lactobacillus 
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plantarum (Kishino and others 2002), Propionibacterium freudenreichii subsp. 
freudenreichii and P. freudenreichii subsp. shermanii (Jiang and others 1998) have been 
identified to produce CLA from free linoleic acid. Our research also showed probiotic 
bacteria, especially Lactobacillus rhamnosus, Propionibacterium freudenreichii subsp. 
shermanii 56, P. freudenreichii subsp. shermanii 51 and P. freudenreichii subsp. freudenreichii 
23, had the ability to produce CLA in the skim milk system containing 1% hydrolyzed soy 
oil emulsified in non-fat dry milk (Xu and others 2004). Yogurt products processed with L. 
rhamnosus, yogurt cultures, and yogurt cultures in conjunction with probiotic bacteria and 
hydrolyzed soy oil as the lipid source resulted in increased CLA content. The inoculation 
concentration of probiotic bacteria had no significant effect on CLA content (Xu and others 
2005). 
Although consumers are interested in healthful food, quality attributes will directly 
affect consumer acceptability of a functional yogurt product (Ott and others 2000; Panagiotidis 
and Tzia 2000). Lactic acid fermentation converts lactose into lactic acid. Lactic acid is 
responsible for the refreshing tart flavor of yogurt. Plain yogurt has a weak but distinctive and 
fragile flavor (Ott and others 2000). Consumers in western countries prefer mild, less acidic 
yogurts. The acid formation also contributes to the viscous, firm and consistent body of the 
yogurt. A typical yogurt texture is smooth, clotless and without fissures, while whey syneresis is 
the most undesirable defect (Panagiotidis and Tzia 2000). Starter culture has been shown to 
affect sensory attributes of yogurt products (Laye and others 1993; Penna and others 1997). 
As a consumer product, the stability of yogurt products in quality attributes was also 
important. 
The desirable organoleptic properties are important for a successful functional food. 
Although there are some flavor and texture studies of commercial yogurts, little attention has 
been paid to the effect of added probiotic bacteria on final yogurt quality characteristics, 
compared with traditional yogurt cultures. The objective of this research was to evaluate the 
quality attributes (acidity, texture and flavor) of yogurt with probiotic bacteria added to 
increase CLA content during the refrigerated storage. The effect of initial concentration of 
starter culture on these quality attributes of yogurts was also studied. 
Materials and Methods 
Starter culture 
Lactobacillus rhamnosus, P. freudenreichii subsp. shermanii 56, P. freudenreichii 
subsp. shermanii 51, and P. freudenreichii subsp. freudenreichii 23 were selected to evaluate 
organoleptic attributes of yogurt produced with the selected bacteria alone or in conjunction 
with traditional yogurt cultures (1:1 ratio of L. delbrueckii subsp. bulgaricus and S. salivarius 
subsp. thermophilus-, YC-180 (YC), Chr. Hansen, Milwaukee, WI). The combination of 
probiotic bacteria and the yogurt culture was at a 1:1 ratio. L. rhamnosus (LB) was obtained 
from Danisco Cultor Inc. (Milwaukee, WI). Propionibacterium freudenreichii subsp. 
freudenreichii 23 (PFF-23), P. freudenreichii subsp. shermanii 56 (PFS-56) and P. 
freudenreichii subsp. shermanii 51 (PFS-51) were obtained from Dr. Bonita Glatz's Collection 
(Iowa State University, Ames, IA) and stored at -80 °C. Lactic acid bacteria were activated in 
Lactobacilli MRS broth (Difco, Detroit, MI) for 15 h at 37 °C and the propionibacteria were 
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activated in sodium lactate broth for 20-22 h at 32 °C. The sodium lactate broth contained 
1% (w/v) tryptic soy broth (Becton Dickinson and Company, Cockeysville, MD), 1% (w/v) 
yeast extract (Becton Dickinson and Company, Sparks, MD), and 1% (w/v) sodium lactate 
syrup (Fisher Scientific, Fair Lawn, NJ). 
Processing of yogurt with hydrolyzed soy oil 
Soybean oil (Wesson, Conagra Grocery Products Company, Irvine, CA) was 
chemically hydrolyzed to increase the content of free fatty acids and emulsified into a 10% 
acacia solution at a 1:1 (w/w) ratio (Xu and others 2004). The mixture was homogenized into 
skim milk (Hy-Vee Inc., West Des Moines, IA) to produce a 1% fat content. The milk solids-
not-fat content was adjusted to 12% through the addition of non-fat dry milk (Hy-Vee Inc., 
West Des Moines, IA). The mixture was heated at 85 °C for 30 min, cooled to 45 °C, and 
inoculated with probiotic bacteria and/or yogurt cultures and incubated as designated in the 
following experiments. 
Experiment 1: Effect of probiotic bacteria on quality attributes of CLA-
enriched yogurt 
The milk samples were inoculated at 107 CFU/mL for single culture (YC, LB, PFS-
56, PFS-51 and PFF-23) or 2 x 107 CFU/mL for the combination of YC with probiotic 
bacteria (YC+LB, YC+PFS-56, YC+PFS-51, and YC+PFF-23) at a 1:1 ratio. The samples 
were incubated at 45 °C until a pH of 4.4 was reached, and then was transferred to 4 °C. 
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Following transfer, the yogurt was sampled at 1, 7, and 14 days for acidity, texture and 
volatile flavor analyses. 
Experiment 2: Effect of initial concentration of starter culture on quality 
attributes of CLA-enriched yogurt 
Yogurt culture, LB, and the mixed cultures of YC and LB, were inoculated at 106, 
107, and 108 CFU/mL. The combination of L. rhamnosus and the yogurt culture was at a 1:1 
ratio. The bacteria treatment was expressed as follows: For example, 7YC means yogurt 
culture with inoculation concentration 107 CFU/mL; 8(YC+LB) means the mixture of yogurt 
culture and L. rhamnosus with inoculation concentration about 2 x 108 CFU/mL. The yogurt 
was incubated at 45 °C until a pH of 4.4 was reached, and then was transferred to 4 °C. 
Following transfer, the yogurt was sampled at 1, 7, and 14 days for acidity, texture and 
volatile flavor analyses. 
Acidity measurement 
The pH of yogurt model systems was recorded using a digital pH meter (Fisher 
Scientific, Accumet Model AB15, Pittsburgh, PA). Titratable acidity was determined by 
titrating a sample (5 g yogurt + 45 mL distilled water) with 0.1N NaOH to an endpoint of pH 
7.0. Titratable acidity was calculated based on lactic acid as the predominant acid and was 
expressed as grams lactic acid per 100 mL yogurt. Sample temperature was 25 °C for each 
analysis. 
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Viscosity and syneresis measurement 
Apparent viscosity was determined by using a RVDVII + Brookfield viscometer 
(Brookfield Engineering Labs Inc., Stoughton, MA) on a 100 mL yogurt sample at room 
temperature (25 °C). Samples were stirred for 20 sec before measurement. All viscosity 
values were measured at 10 rpm with spindle #5. Readings were converted to centipoise units 
(Gassem and Frank 1991). Syneresis (%) was expressed as volume of drained whey per 100 
mL yogurt (Rodarte and others 1993). 
Volatile Flavor Analysis 
Solid-phase microextraction (SPME) technique was used for the isolation and 
concentration of volatile flavor compounds. A representative yogurt sample (20 g) and 5 mL 
distilled water was transferred to a 100 mL headspace bottle and sealed with a Teflon 
septum to prevent volatile loss. Yogurt samples were stirred and held in a 40 °C water bath to 
increase the concentration of volatile compounds in the sample headspace. The yogurt 
sample was allowed to equilibrate and absorb onto the SPME fiber (2 cm-50/30 (j.m 
divinylbenzene (DVB) / Carboxen / Polydimethylsiloxane (PDMS), Supelco, Inc., 
Bellefonte, PA) for 45 min. The volatiles were thermally desorbed (220 °C for 3 min) from 
the SPME fiber via a splitless injection port onto the GC column. 
A gas chromatograph equipped with a flame ionization detector (Model HP6890, 
Hewlett Packard Inc.) and a fused-silica capillary column (SPB-1000, 30 m x 0.25 mm x 
0.25 |am film thickness, Supelco, Inc.) was used for separation of flavor compounds. The 
column pressure was set at 124.0 KPa with a helium flow rate of 1.9 mL/min. The 
temperature of the GC oven was held initially at 30 °C for 3 min, increased to 80 °C at 5 
°C/min, increased to 95 °C at 4 °C/min, increased to 115 °C at 5 °C/min, and finally increased 
to 190 °C at 10 °C/min and held for 10 min. The total run time was 38.25 min. The detector 
temperature was 220 °C. Flow rates of detector gases were air at 400 mL/min, hydrogen at 30 
mL/min and nitrogen (make-up gas) at 25 mL/min. Volatile flavor standards were identified 
using authentic standards (Sigma-Aldrich, Milwaukee, WI; AccuStandard, Inc., New Haven, 
CT). 
Volatile flavor compounds were identified and confirmed with a gas chromatograph-
mass spectrometer (Micromass GCT, Waters Corp., Milford, MA). The GC conditions were 
the same as those of the chromatographic analysis. The mass spectrometer conditions were 
set as the following: electron ionization positive (EI+) polarity, source electron energy at 70 
eV, source electron current at 200 juA., ion source temperature at 180 °C, source ion repel 1er 
at 0.8 V, electron multiplier voltage at 2700 V, and scan range between 41 and 400 m/z at a 
frequency of scanning cycle every 0.75 sec. Mass spectra of the volatile flavor compounds 
were compared to a spectral library (Wiley Library) and a flavor and fragrance database 
(Flavor WORKS, Flavometrics, version 2.0, Anaheim Hills, CA) for identification. 
Statistical analysis 
Experiment 1 was designed as a 2-way factorial experiment with bacterial culture and 
storage time as the main factors. Each treatment was replicated three times. Experiment 2 
was designed as a 3-way factorial experiment with inoculation level, bacterial culture and 
storage time as the main factors. Each treatment was replicated three times. The experimental 
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data were analyzed using analysis of variance (mixed linear model procedures) and Duncan 
multiple range test (SAS version 8.2, Cary, NC, 2004) with a significance level of 0.05. 
Principal component analysis (PCA), using varimax orthogonal rotation, was used to 
examine relationships or groupings of volatile flavor compounds based on bacterial culture 
effects using the SYSTAT statistical analysis package (version 9.01, SPSS, Inc., Chicago, 
IL). The biplot of the PCA was completed to show the positions of bacterial cultures in the 
plane constructed by the first two principal components. 
Results and Discussion 
Effect of bacteria on quality attributes of CLA-enriched yogurt 
In general, interactions between bacteria and storage time did not have a significant 
effect on the quality attributes of the yogurts. For each starter culture treatment, no significant 
difference in the quality attributes, such as pH, titratable acidity, viscosity, degree of syneresis 
and flavor, was observed when the storage time increased from 1 to 14 days at 4 °C. Therefore, 
data were pooled to focus on the effects of the bacterial culture on the quality attributes of 
yogurt products. 
pH and titratable acidity of yogurts 
The yogurts produced with the yogurt cultures, L. rhamnosus, or the propionibacteria 
with the yogurt cultures had pHs in the range of 4.10 to 4.33 (Table 1). These pH values were 
significantly lower than for the yogurts produced with the propionibacteria (PFF-23, PFS-56, 
and PFS-51) alone. For propionibacteria, the rate of pH decrease was significantly slower than 
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for the lactic acid bacteria. The above results are consistent with the growth of the starter 
cultures (Xu and others 2005). The lower growth rate of propionibacteria resulted in a slower 
rate of acid production and pH decrease in the yogurts. 
The samples with only the yogurt cultures (L. bulgaricus and S. thermophilics) had the 
highest titratable acidity (1.79 g lactic acid/100mL yogurt) (Table 1). The yogurts with the 
probiotic bacteria alone or with probiotic bacteria plus yogurt cultures had lower titratable 
acidities. The combination of P. freudenreichii subsp. shermanii 56 and yogurt culture 
showed the lowest titratable acidity through the whole storage time. 
The titratable acidity and pH data did not show parallel effects. In the titratable 
acidity determination, the acidity is reported based on lactic acid content, which is the 
predominant organic acid in dairy products. Lactic acid bacteria showed a significantly 
higher growth rate than propionibacteria (Xu and others 2005). Lactic acid bacteria produce 
lactic acid as the major product by exclusively fermenting hexose. The genus Lactobacillus is 
the preferred species to produce lactic acid (Martin 1996). However, for propionibacteria, lactic 
acid production in fermentation process is only an intermediate step in the production of 
other organic acids, such as propionic acid and acetic acid. Propionic acid is the main 
metabolic product of propionibacteria (Vorobjeva 1999). The pKa values of lactic acid and 
propionic acid are 3.86 and 4.87, respectively. A lower pKa indicates a greater dissociation of 
weak acids so that higher concentration of H1" is produced. The difference in the pKa values of 
the organic acids would contribute to a lower pH in yogurt produced with lactic acid bacteria 
than in yogurt produced with propionibacteria. 
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Viscosity and syneresis of yogurts 
Yogurt processed with the yogurt cultures, L. rhamnosus, or the propionibacteria with 
the yogurt cultures was significantly more viscous and exhibited less syneresis than yogurt 
processed with the propionibacteria (PFF-23, PFS-56, and PFS-51) alone (Table 1). Prolonging 
storage from 1 to 14 days at 4 °C resulted in no significant difference in viscosity and syneresis 
for all starter culture treatments. Yogurt culture demonstrated the lowest degree of syneresis. 
Syneresis is an undesirable textural property of yogurt, which is caused by a spontaneous release 
of water from the gel and accompanied by a reduction in volume (Dannenberg and Kessler 
1988). The increase in water-binding capacity of proteins increases curd stability during 
fermentation and storage (Langton 1991). 
The combination of the yogurt cultures with the propionibacteria increased acid 
production and improved the textural characteristics of the yogurts to result in yogurts with 
texture similar to that of the control yogurt. The difference in the textural characteristics of the 
yogurts produced with propionibacteria in comparison to other treatments is attributed in part to 
the lower rate of acid production by propionibacteria. A comparison of pH and syneresis 
showed that less syneresis occurred when the pH ranged from 4.10-4.33 (Table 1). The results 
for viscosity and syneresis of yogurts are consistent with the limited growth and acid production 
by the propionibacteria. 
Volatile flavor compounds in yogurts 
Yogurt flavor is mainly generated from fermentation by the starter cultures, the 
ingredients of yogurt production, and heat processing. Fermentation is a major process to 
produce lactic acid and volatile compounds. Most of the 34 volatile flavor compounds 
identified, such as 2,3-butanedione, 2,3-pentanedione, benzaldehyde, acetaldehyde, acetic acid, 
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ethyl acetate, and 2-heptanone, have been identified in yogurt and milk (Labropoulos and 
others 1982; Kang and others 1988; Imhof and others 1995; Ott and others 1997). In our 
research, hydrolyzed soy oil was used as a lipid source to increase CLA content in yogurt 
products. Therefore, lipid oxidation reactions could produce some compounds, such as trans-2-
nonenal, l-octen-3-ol or trans-3-octen-2-one, which are not typical yogurt flavors (Ott and 
others 1997). 
Principal component analysis 
Principal component analysis (PCA) is one of the most commonly used statistical 
techniques to study complexities in flavor systems. Principal component analysis identifies 
patterns of interactions between variables to condense a large set of data into groups of similar 
characteristics. Principal component analysis grouped the volatile flavor compounds into 4 
principal components (PC). PC-1 (14.3%) contained 7 volatile flavor compounds, PC-2 (11.5 
%) contained 5 volatile flavor compounds, PC-3 (8.7%) contained 4 volatile flavor compounds 
and PC-4 (7.5%) contained 18 volatile flavor compounds (Table 2). Volatile flavor compounds 
were not exclusively grouped into the principal components based on the class of compound, i.e. 
aldehydes, ketones, alcohols or esters. 
The yogurt produced with propionibacteria alone formed a significantly different 
grouping from that produced with yogurt culture, L. rhamnosus, and the probiotic bacteria with 
the yogurt culture (Figure 1). It is reasonable to assume that yogurt produced with PFS-56, PFS-
51 and PFF-23 share certain flavor properties. No significant differences were observed for 
yogurts processed with the other bacterial treatments. These results demonstrated that the CLA-
enriched yogurt products processed with the incorporation of yogurt culture and probiotic 
bacteria showed similar flavor characteristics as control yogurt produced by yogurt cultures. 
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However, the yogurt produced with only propionibacteria did not have typical yogurt flavor 
characteristics. 
Effect of bacteria and storage on volatile flavor compounds 
The aroma profile of yogurts did not change significantly during refrigerated storage. 
This result is in agreement with another study (Imhof and Bosset 1994). No interaction between 
bacterial culture and storage time was detected for all flavor compounds, except for propionic 
acid. Therefore, the flavor data were pooled to determine the effect of starter culture on volatile 
organic compounds (Table 2). 
Principal component-1 (PC-1) included two major volatiles, 2, 3-butanedione and 2, 3-
pentanedione, known to contribute to typical yogurt flavor (Ott and others 1999). The yogurt 
produced by propionibacteria alone showed higher content of 2, 3-butanedione than the yogurt 
processed with other cultures. In particular, PFS-51 produced significantly higher amounts of 2, 
3-butanedione. Other bacteria resulted in no difference in the production of 2, 3-butanedione 
compared to the yogurt culture. The yogurt processed by yogurt culture and PFS-51 produced a 
significantly lower content of 2, 3-butanedione than PFS-51. These results clearly showed the 
incorporation of probiotic bacteria with yogurt culture effectively improved the yogurt flavor 
and produced flavor similar to the control yogurt culture. 
Another important volatile compound is 2, 3-pentanedione. No significant difference 
was detected for most bacterial cultures in the production of 2, 3-pentanedione. Only (YC+LB) 
and LB showed a lower content of 2, 3-pentanedione than YC. During fermentation, 2, 3-
butanedione and 2, 3-pentanedione are produced by oxidative decarboxylation of their 
precursors, 2-acetolactate and 2-acetohydroxybutyrate (Ramos and others 1994). The 2-
acetolactate and 2-acetohydroxybutyrate are the metabolic intermediates of the branched chain 
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amino acids, valine and isoleucine, respectively. The two precursors are unstable under the 
conditions of heating and oxygen. The formation of 2, 3-butanedione and 2, 3-pentanedione is 
reduced by 2-acetolactate-dehydrogenase which directly converts their precursors into acetoin 
(Imhof and others 1995). 
Principal component-1 (PC-1) also contained several untypical yogurt flavor 
compounds, such as dimethyl disulfide and undecanal. In general, the yogurt produced by 
propionibacteria alone demonstrated significantly higher contents of the flavor compounds that 
grouped into PC-1 than other bacteria treatments. However, the combination of yogurt culture 
with propionibacteria effectively reduced the content of these compounds. 
In PC-2, acetic acid is a typical yogurt flavor compound. It produces a sour and pungent 
aroma. Lactic acid bacteria mainly produce lactic acid, while propionibacteria produce 
propionic acid as an important end-product. Acetic acid is only one of the acids produced by 
lactic acid bacteria and propionibacteria. Unlike other flavor compounds in PC-2, the content of 
acetic acid was lower in the yogurt produced by propionibacteria alone than in the yogurt 
produced by other bacteria. However, the incorporation of propionibacteria and yogurt culture 
increased the amount of acetic acid. The pH data and microbial counts showed consistent results 
with the content of acetic acid (Tables 1 and 2, Xu and others 2005). When growth of 
propionibacteria was slow, acetic acid production was reduced. However, the presence of yogurt 
culture greatly stimulated the growth of propionibacteria (Xu and others 2005). Thus, the yogurt 
processed with propionibacteria and yogurt cultures resulted in increased contents of acetic acid. 
The yogurt produced by propionibacteria also showed significant differences from that 
produced with other bacteria in PC-3 and PC-4. In PC-3, hexanal, a product from the oxidation 
of linoleic acid, contributes to typical yogurt flavor. However, it is presumed that excessive 
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hexanal production causes strong green, grassy and penetrating aroma and disrupts flavor 
balance (Imhof and others 1995; McGorrin 2000). In our research, the yogurt produced with 
propionibacteria, especially PFS-56, resulted in higher concentration of hexanal than with other 
bacteria. However, the addition of yogurt culture to propionibacteria significantly reduced the 
production of hexanal. S. thermophilus was more effective than L. bulgaricus in reducing the 
hexanal content of fermented peanut milk (Lee and Beuchat 1991). The metabolism of 
bifidobacteria has been reported to break down hexanal and reduce undesirable flavor of 
fermented soy milk products (Scalabrini and others 1998). Our study showed similar results in 
that lactic acid bacteria could effectively reduce the hexanal content of fermented dairy 
products. 
In PC-4, propionic acid is a characteristic flavor compound produced by 
propionibacteria. In general, the propionibacteria produced a significantly higher content of 
propionic acid than did the other bacterial treatments. However, the addition of yogurt cultures 
effectively reduced the content of propionic acid to a similar level as control yogurt. Our results 
showed the propionic acid content increased with the time extension from 1 d to 7 d. These 
results were consistent with the growth of propionibacteria (Xu and others 2005). 
The aroma profile of yogurt consists of a unique combination of volatile organic 
compounds. Correct ratios among the different key compounds are essential for a balanced 
aroma (Ott and others 2000). The volatile compounds contribute to the characteristic note of 
yogurt but can also cause off-flavors depending on their concentrations compared to other flavor 
compounds. The reason why the yogurts processed with propionibacteria resulted in untypical 
flavor was mainly attributed to the different ratio of key flavor compounds compared to the 
control yogurt. Some desirable fermentation end-products, such as 2,3-butanedione, 2,3-
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pentanedione and acetic acid, showed different content in yogurts produced with 
propionibacteria alone compared to those produced with other bacteria. Overproduction of 2, 3-
butanedione by propionibacteria causes a harsh flavor (Lindsay and others 1965). Some off-
flavor compounds, such as dimethyl disulfide and undecanal, were present in higher 
concentration in the yogurt with propionibacteria alone than in the other yogurts. All these 
differences caused a different ratio of flavor compounds and different flavor characteristics from 
control yogurt. 
The proper acidity is also closely related to yogurt flavor. Desirable pH for typical 
yogurt flavor ranges from pH 4.0 to 4.4 (Sandine and others 1972). Our study showed similar 
results. The yogurt produced by yogurt culture, L. rhamnosus, and the probiotic bacteria with 
the yogurt cultures resulted in pH 4.0 to 4.4 and similar flavor characteristics (Table 1; Figure 1). 
However, the yogurt produced by propionibacteria had a higher pH (4.64 to 5.02) and produced 
different flavor quality compared to control yogurt. 
Effect of initial concentration of starter culture on quality attributes of 
CLA-enriched yogurt 
Acid production of yogurts 
In this study, storage time did not have significant effect on pH and titratable acidity 
of yogurts during the 14-day storage time at 4 °C. Thus, data were pooled to determine the 
effects of inoculation level and bacterial cultures on the acidity of yogurt products. Effect of 
inoculation level and bacterial cultures on pH and titratable acidity changes in yogurts are 
presented in Table 3. As lactic acid bacteria, YC, LB, and LB in conjunction with YC rapidly 
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decreased the pH of the yogurt after 1 day storage (P<0.05), followed by much more gradual 
changes throughout the storage period at 4 °C. The yogurts produced with 8(YC+LB), 
6(YC+LB) and 7LB had lower pH values than other starter cultures. The pH of the yogurt 
processed with 6LB decreased very slowly throughout the storage period as a result of the 
slower fermentation process. The yogurt processed with 6(YC+LB) showed a faster decrease 
in pH than 6LB (p<0.05). The addition of YC increased the fermentation process through the 
rapid growth of yogurt cultures. However, the effect of YC on fermentation rate may also be 
related to the inoculation level. 
The pH was considered an effective indicator of starter culture activity as it was 
directly related to population count. The microbial counts of yogurt gradually decreased with 
the slight pH drop (Xu and others 2005). The bacteria in yogurt are often exposed to pH 4.3-
4.6. Low pH was not suitable for the survivability of bacteria. For example, LB survived best 
at pH 7 and 8. The number of LB decreased to zero after 48 h at pH 2 (Oliveira and others 
2002). Therefore, the increase of acidity would affect the viable counts of bacteria in the 
yogurts. 
The lactic acid bacteria tend to decrease pH and increase titratable acidity by 
production of lactic acid. The yogurt produced by 8(YC+LB) showed the highest titratable 
acidity (Table 3). This result was consistent with the pH drop of starter culture. On the other 
hand, 6LB resulted in the lowest titratable acidity. In this study, the titratable acidity of 
yogurt appeared to be consistent to the results by Kehagias and Dalles (1984). The titratable 
acidity reached about 1.0 g lactic acid/lOOmL yogurt which could be considered as a good 
quality yogurt. The acid production will affect flavor of yogurt. High acidity (>1.2 g lactic 
acid/lOOmL yogurt) would lead to unpleasant acid tastes. Our results indicated that the 
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titratable acidity of yogurt was close to the optimal acidity (1.0 g lactic acid/lOOmL yogurt) 
(Pinthong and others 1980). 
Titratable acidity was determined by lactic acid content, which is the predominant 
organic acid in dairy products. Yogurt cultures and L. rhamnosus both belong to the genus 
Lactobacillus which produces lactic acid as its major product by the fermentation hexose. In 
this study, titratable acidity is a more precise measure than pH value to describe the acid 
production of yogurts. For lactic acid bacteria, the pH and titratable acidity showed parallel 
changes. 
Texture properties of yogurt 
In this study, storage did not have a significant effect on texture of yogurts. 
Therefore, data were pooled to evaluate the effects of bacterial treatments on the viscosity 
and syneresis of yogurt products. In general, bacterial treatments had no significant effect on 
the viscosity of yogurts at 4 °C (Table 3). The viscosity of yogurt produced with 6LB was the 
lowest. It is possible that the optimum pH wasn't reached so that gel formation of yogurt was 
affected. Comparing the viscosity of the yogurt produced with 6LB and 6(YC+LB), the 
incorporation of LB and YC significantly increased the viscosity from 71,000 to 147,000 
centipoise. However, no significant differences were observed for LB and YC+LB when the 
inoculation level reached 107 or 108CFU/mL. This result suggests that the combination of YC 
and LB increases the viscosity of yogurts compared to YC or LB alone at a lower inoculation 
level. 
The degree of syneresis describes the stability of yogurts by measuring the liquid 
separation. Table 3 showed that bacteria treatments had no significant effect on the degree of 
syneresis of yogurts (P>0.05). The yogurt processed with YC, LB, or LB in conjunction with 
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YC had a low degree of syneresis at 4 °C. In Table 3, the yogurt processed with 8(YC+LB) 
with higher acidity showed less syneresis. Oliveria and others (2002) found similar results in 
lactic beverage for the relationship between acidity and syneresis. In this study, the yogurt 
after fermentation showed a firm homogeneous curd with little separation of whey. 
Volatile flavor compounds in yogurts 
Since the storage time did not significantly affect the aroma profile of yogurts, the flavor 
data were pooled to determine the effect of inoculation level and bacterial culture on volatile 
compounds (Table 4). Among characteristic yogurt volatile compounds, acetaldehyde, 2, 3-
butanedione, and benzaldehyde are important fermentation products (Imhof and others 1995; 
Ott and others 1997). Yogurt inoculated with LB at 106 or 107CFU/mL had higher acetaldehyde 
and 2, 3-butanedione contents than control yogurt (7YC). The overproduction of acetaldehyde 
in relation to 2, 3-butanedione has been reported to cause harsh flavor (Lindsay and others 
1965). Similarly, the yogurt produced with YC demonstrated lower content of benzaldehyde 
than the yogurt processed with LB. However, the incorporation LB into YC at 107CFU/mL 
effectively decreased the content of benzaldehyde. The yogurt processed with 7(YC+LB) 
often produced typical volatile compounds, such as acetaldehyde, 2, 3-butanedione and 
benzaldehyde, which is comparable to the control yogurt. 
Some untypical volatile compounds, such as trans-2-nonenal, l-octen-3-ol or 
undecanal, were identified in the aroma profile of yogurts. Since hydrolyzed soy oil was used 
to increase CLA content in yogurt products, lipid oxidation reactions contributed to the 
formation of oxidation products. The results showed that LB in conjunction with YC decreased 
the content of off-flavor compounds in yogurts compared to LB alone. The content of undecanal 
114 
was significantly lower in the yogurt produced with 7(YC+LB) than in yogurt that processed 
with 7LB and produced similar flavor characteristics as the control yogurt. 
Inoculation level of YC, LB or the mixture of YC and LB did not result in significant 
differences for most volatile flavor compounds. However, some volatile compounds were 
affected by different bacteria concentration. For the yogurt processed with YC, the content of 
several fermentation products greatly increased with the increased inoculation level. When the 
initial bacteria concentration was 108CFU/mL, some volatile compounds, such as acetic acid, 
methanol, 2-propanol, ethyl pentanoate or butanoic acid, were formed in a higher 
concentration than at other inoculation levels. The increased concentration of bacteria may 
facilitate the lactic acid fermentation process. However, the yogurt processed with LB alone 
produced higher contents of volatile compounds, such as acetic acid, acetaldehyde, 2, 3-
pentanedione or benzaldehyde, at lower inoculation levels (106 or 107CFU/mL) than at 
108CFU/mL. For certain probiotic bacteria, the continuous increase in initial bacteria 
concentration had no impact on the formation of volatile compounds. Overall, the optimum 
inoculation level and bacterial cultures had some impact on volatile compounds of yogurts. 
Conclusions 
The addition of probiotic bacteria to yogurt to increase CLA content must not only 
improve nutritional value but also result in a product with desirable quality attributes. In our 
study, the incorporation of probiotic bacteria with yogurt culture and unique processing 
methods not only increased CLA content but also produced similar quality attributes as 
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control yogurt. Yogurt processed with yogurt culture, L. rhamnosus, and probiotic bacteria in 
conjunction with yogurt culture showed good storage stability with respect to acidity, texture 
and flavor attributes. Yogurt culture in conjunction with probiotic bacteria provided an 
effective approach to produce similar CLA content and quality characteristics as control yogurt. 
The yogurt processed with the propionibacteria alone showed undesirable quality attributes 
compared to the control yogurt. Compared to other treatments, the yogurt produced with 
7(YC+LB), 6(YC+LB), 6YC and 8LB showed more similar acidity, texture and flavor as 
control yogurt. Inoculation level of L. rhamnosus and yogurt cultures had no significant 
effect on texture, but affected acidity and volatile flavor compounds of yogurts. This research 
demonstrated that functional probiotic yogurt products with increased CLA contents have 
acceptable quality attributes and a potential for greater consumer acceptability. 
References 
Chin SF, Storkson JM, Albright KJ, Cook ME, Pariza MW. 1994. Conjugated linoleic acid is a growth factor 
for rats as shown by enhanced weight gain and improved feed efficiency. J Nutr 124: 2344-9. 
Corl BA, Baumgard LH, Dwyer DA, Griinari JM, Phillips BS, Bauman DE. 2001. The role of U9 - desaturase 
in the production of cis-9, trans-11 CLA. J Nutr Biochem 12:622-30. 
Dannenberg F, Kessler HG. 1988. Effect of denaturation of Q-lactoglobulin on texture properties of set-style 
nonfat yogurt. 1. syneresis. Milchwissenschaft 43:632-5. 
Gassem AM, Frank FJ. 1991. Physical properties of yogurt made from milk treated with proteolytic enzymes. J 
Dairy Sci 74:1503-11. 
116 
Hayek MG, Han SN, Wu D, Warkins BA, Meydani M, Dorsey JL, Smith DE, Meydani IN. 1999. Dietary 
conjugated linoleic acid influences the immune response of young and old C57BL/6NCrIBR mice. J Nutr 
129:32-8. 
Houseknecht K, Helvel J, Moya-Camarena S, Portocarrero C, Peck L, Nickel K, Belury M. 1998. Dietary 
conjugated linoleic acid normalize impaired glucose tolerance in Zucker diabetic fatty fa/fa rat. Biochem 
Biophys Res Commun 244:678-82. 
Imhof R, Bosset JO. 1994. Quantitative GC-MS analysis of volatile flavor compounds in pasteurized milk and 
fermented milk products applying standard addition method. Lebensm -Wiss-Technol 27:265-9. 
Imhof R, Glatti H, Bosset JO. 1995. Volatile organic compounds produced by thermophilic and mesophilic 
single strain dairy starter cultures. Lebensm-Wiss-Technol 28:78-86. 
Jiang J, Bjôrch, Fondén R. 1998. Production of conjugated linoleic acid by dairy starter cultures. J Appl 
Microbiol 85:95-102. 
Kang YJ, Frank JF, Lillard DA. 1988. Gas chromatographic detection of yogurt flavor compounds and changes 
during refrigerated storage. J Cult Dairy Prod 11:6-9. 
Kehagias CH, Dalles TN. 1984. Bacteriological and biochemical characteristics of various types of yogurt made 
from sheep's and cow's milk. J Food Protec 47(10):760-1. 
Kishino S, Ogawa J, Omura Y, Matsumura K, Shimizu S. 2002. Conjugated linoleic acid production from 
linoleic acid by lactic acid bacteria. J Am Oil Chem Soc 79:159-63. 
Labropoulos AE, Palmer JK, Tao P. 1982. Flavor evaluation and characterization of yogurt as affected by ultra­
high temperature and vat processes. J Dairy Sci 65:191-6. 
Langton M. 1991. The microstructure of yogurts. SIK Report Nr 580:1-26. 
Laye I, Karleskind D, Morr CV. 1993. Chemical, microbiological and sensory properties of plain nonfat yogurt. 
J Food Sci 58:991-5. 
Lee C, B eue hat LR. 1991. Changes in chemical composition and sensory qualities of peanut milk fermented 
with lactic acid bacteria. Int J Food Microbiol 13(4):273-83. 
Lin TY, Lin CW, Lee CH. 1999. Conjugated linoleic acid concentration as affected by lactic cultures and added 
linoleic acid. Food Chem 67:1-5. 
117 
Lindsay RC, Day EA, Sandine WE. 1965. Green flavor defect in lactic starter cultures. J Dairy Sci 48:863. 
Martin AM. 1996. Fermentation processes for the production of lactic acid. In: Bozoglu TF, Ray B, editors. 
Lactic acid bacteria: current advances in metabolism, genetics and applications. Berlin: Springer, p 274-81. 
McGonin RJ. 2000. Advances in dairy flavor chemistry. In: Spanier AM, Shahidi F, Parliment TH, Massinan C, 
Ho CT, Contis ET, editors. Food flavors and chemistry. Cambridge: Athenaeum Press Ltd. p 68-81. 
Nicolosi RJ, Rogers EJ, Kritchevsky D, Scimecaand J A, Huth PJ. 1997. Dietary conjugated linoleic acid 
reduces plasma lipoproteins and early aortic atherosclerosis in hypercholesterolemic hamsters. Artery 22:266-
77. 
Oliveira MN, Sodini I, Remeuf F, Tissier JP, Corrieu G. 2002. Manufacture of fermented lactic beverages 
containing probiotic cultures. J Food Sci 67(6):2336-41. 
Ott A, Fay LB, Chaintreau A. 1997. Determination and origin of the aroma impact compounds of yogurt flavor. 
J Agric Food Chem 45: 850-8. 
Ott A, Germond JE, Baumgartner M, Chaintreau A. 1999. Aroma comparisons of traditional and mild yogurts: 
headspace gas chromatograph quantification of volatiles and origin of D-diketones. J Agric Food Chem 47: 
2379-85. 
Ott A, Hugi A, Baumgartner M, Chaintreau A. 2000. Sensory investigation of yogurt flavor perception: mutual 
influence of volatiles and acidity. J Agric Food Chem 48: 441-50. 
Panagiotidis P, Tzia C. 2000. Effect of milk composition and heating on flavor and aroma of yogurt. In: Spanier 
AM, Shahidi F, Parliment TH, Massinan C, Ho CT, Contis ET, editors. Food flavors and chemistry. 
Cambridge: Athenaeum Press Ltd. p 160-3. 
Park Y, Albright KJ, Liu W, Storkson JM, Cook ME, Pariza MW. 1997. Effect of conjugated linoleic acid on 
body composition in mice. Lipids 32:853-8. 
Penna ALB, Baruffaldi R, Oliveira MN. 1997. Optimization of yogurt production using demineralized whey. J 
Food Sci 62:846-50. 
Pinthong R, Macrae R, Rothwell J. 1980. The development of a soya-based yoghurt I. acid production by lactic 
acid bacteria. J Food Technol 15:647-52. 
118 
Ramos A, Jordan KN, Cogan TM, Santos H. 1994. 13C Nuclear magnetic resonance studies of citrate and 
glucose metabolism by Lactococcus lactis. Appl Environ Microbiol 60:1739-48. 
Rastall RA, Fuller R, Gaskins HR, Gibson GR. 2000. Colonic functional foods. In: Gibson GR, Williams CM, 
editors. Functional foods: concept to product. Cambridge: Woodhead Publishing Limited, p 76. 
Rodarte CW, Galvan MV, Farres A, Gallardo F, Marshall VE, Garibar MG. 1993. Yogurt production from 
reconstituted skim milk powders using different polymer and nonpolymer forming starter cultures. J Dairy 
Res 60:247-54. 
Sandine WE, Daly C, Elliker PR, Vedamuthy ER. 1972. Causes and control of culture-related flavor defects on 
cultured dairy products. J Dairy Sci 55:1035. 
Scalabrini P, Ross M, Spettoli P, Matteuzzi D. 1998. Characterization of bifidobacterium strains for use in 
soymilk fermentation. Int J Food Microbiol 39:213-9. 
Vorobjeva LI. 1999. Propionibacteria. Netherlands: Kluwer Academic Publishers, p 128-9. 
Xu S, Boylston TD, Glatz BA. 2004. Effect of lipid source on probiotic bacteria and conjugated linoleic acid 
formation in milk model systems. J Am Oil Chem Soc 81:589-95. 
Xu S, Boylston TD, Glatz BA. 2005. Production of conjugated linoleic acid in yogurt products through 
incorporation of probiotic bacteria. J Food Sci (to be submitted). 
119 
ACKNOWLEDGEMENTS 
Funding for the research was provided, in part by, the National Dairy Council and 
NASA Food Technology Commercial Space Center. This article of the Iowa Agriculture and 
Home Economics Experiment Station, Ames, Iowa, Project Number 3574, was supported by 
Hatch Act and State of Iowa Funds. L. rhamnosus was donated by Danisco Cultor Inc., 
Milwaukee, WI. The yogurt cultures were provided by Chr. Hansen, Milwaukee, WI. The 
statistical consultation of Dr. Philip Dixon is appreciated. 
120 
Table 1- Acidity and texture of yogurts processed with probiotic bacteria and/or 
yogurt cultures8 
Strain Titratable acidity pHc Viscosity Degree of 
(g lactic acid (centipoise) syneresis (%) 
/100ml yogurt)" 
YC 1.79a 4.23c 225,000a 9b 
YC + LB 1.17bc 4.10c 224,000a 12b 
LB 1,26bc 4.14c 237,000a 15b 
YC + PFS-51 1.02bc 4.16c 234,000a 16b 
RFS-51 1,04bc 4.72b 57,300bc 44a 
YC + PFS-56 0.83c 4.33c 269,000a 14b 
PFS-56 1.35b 5.02a 134,000b 47a 
YC + PFF-23 1.04bc 4.32c 223,000a 12b 
PFF-23 1.17bc 4.64b 47,400c 51a 
"Means in the same column followed by the same superscripts (a-c) are not significantly different (p > 0.05). Means are 
triplicate analyses of three replications. Data were pooled across storage times. 
bAverage titratable acidity of all treatments prior to fermentation was 0.31. 
"Average pH of all treatments prior to fermentation was 5.96. 
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• YC+LB 
O LB 
-YC 
• YC+PFS51 
YC+PFF23 
AYC+PFS56 
• PFF23 
A PFS56 
o PFS51 
Factor 1 
Figure 1 - Plot of the PCA of yogurt showing associations between bacterial cultures 
and analytical data. Object coordinates representing individual bacterium at 1,7 and 
14 days with three replications. 
Table 2 - Effects of bacteria treatments on the volatile flavor compounds of yogurt8 
Bacterial Cultures 
Flavor 
Compounds YC 
YC 
+LB 
YC+ 
PFS-56 
YC+ 
PFS-51 
YC+ 
PFF-23 LB PFS-56 PFS-51 PFF-23 
COMPONENT 1 
(PC-1) 
2-propanol 9.84c 12.45c 9.50c 10.17c 21.57b 12.69c 89.58a 116.67a 94.78a 
isobutyl alcohol 35.92c 27.47c 34.39c 28.99c 38.36c 25.98c 63.08ab 61.39ab 72.43a 
2,3-pentanedione 80.07ab 52.46c 71.09bc 68.36bc 78.56ab 46.95c 97.95a 81.87ab 104.54a 
undecanal 31.61 be 22.24c 16.00c 20.45c 26.97bc 16.38c 45.15ab 41,53ab 52.96a 
2,3-butanedione 58.55d 122.40bcd 85.14bcd 73.05cd 93.91 bed 115.98bcd 141.89b 206.26a 128.41 be 
ethylbenzene 18.11 bed 12.77cde 27.74a 15.75bcde 19.06abc 23.07ab 9.36de 9.70cde 8.41 e 
dimethyl disulfide 9.75b 8.46b 8.19b 5.98b 8.53b 10.82b 95.63a 231.71a 227.57a 
COMPONENT 2 
(PC-2) 
1-hexanol 108.27bcd 68.97de 137.93ab 122.18bc 58.56de 46.08e 144.19ab 186.67a 82.38cde 
2-undecanone 20.10a 15.32abc 15.89ab 17.56ab 10.69c 15.17abc 17.49ab 16.59ab 11,28bc 
1 -butanol 33.32a 14.28b 27.29ab 32.44ab 12.92b 14.24b 21.40ab 13.15b 14.93ab 
2-pentylfuran 101.43b 174.67a 71.39b 71.12b 180.68a 128.75ab 117.92ab 130.18ab 100.64b 
acetic acid 61.17bc 286.52a 75.71 be 86.66b 76.45bc 266.63a 7.86d 21 OBcd 4.60d 
COMPONENT 3 
(PC-3) 
hexanal 54.59b 35.36bc 27.05c 40.15bc 33.26bc 40.80bc 72.71a 67.96ab 67.74ab 
ethyl pentanoate 211.80 180.42 129.98 178.67 192.40 139.56 153.80 185.88 289.67 
octanoic acid 89.75abc 65.75d 70.87cd 76.68bcd 95.51 ab 86.24abcd 71.91 bed 77.05bcd 109.74a 
2-nonanone 34.49b 31.49b 55.29ab 44.92ab 70.55a 42.19b 58.17ab 45.47ab 71.59a 
Table 2 - (Continued) 
COMPONENT 4 
(PC-4) 
methanol 11.03ab 11.94a 7.16bcd 7.56bcd 8.73abcd 10.70ab 10.31 abc 5.17d 6.42cd 
trans-3-octen-2-
one 14.34a 12.38ab 9.00bc 11.13abc 7.42c 12.76ab 11,95ab 9.21 be 10.74abc 
1 -octen-3-ol 83.84 74.51 64.32 72.80 78.52 96.05 89.53 83.45 80.07 
benzaldehyde 49.59bcd 25.34d 105.77a 89.03ab 105.25a 28.03cd 68.57abc 69.17abc 50.1 Bbcd 
acetaldehyde 53.54 54.59 39.60 36.74 48.39 62.99 58.74 45.39 44.48 
2-heptanone 979.10a 764.40ab 777.4ab 754.70ab 450.70abc 685.10ab 220.30d 482.30abc 301.10bc 
ethyl butanoate 65.43 51.65 47.16 67.99 67.64 51.80 42.75 38.08 53.55 
1 -octanol 19.28c 21.40c 198.28b 336.76a 21.85c 24.52c 42.79c 48.61c 31.21c 
trans-2-nonenal 17.42bc 10.56c 27.58a 23.73ab 24.9Oab 11.90c 16.37bc 11.95c 19.19abc 
nonanal 15.75a 15.76a 11.58a 12.20a 13.79a 16.75a 14.28a 8.91b 13.81a 
hexanoic acid 14.00ab 4.04c 7.00bc 3.97c 3.29c 3.51c 4.90c 15.63a 6.03bc 
5-nonanone 17.96d 30.30cd 62.54ab 34.51 be 21.14cd 18.93d 42.00bc 72.18a 34.34bc 
d-limonene 140.38a 53.20bcd 79.86bc 87.57b 92.91b 39.06cd 30.30d 65.52bcd BO.ôôbc 
butanoic acid 8.71 ab 4.37b 10.43ab 5.38b 9.65ab 18.54a 6.00b B.ôBab 7.62ab 
ethyl heptanoate 21.10c 27.35bc 27.20bc 68.48ab 27.06bc 92.59a 43.92b 40.92b 21.23c 
3-heptanone 10.84c 45.82b 7.38c 6.30c 6.74c 14.16c 121.27a 7.44c 11.07c 
1 -pentanol 1499.4Obc 1544.30bc 1919.40b 1062.30c 2074.50b 2032.60b 2884.00a 3134.30a 1798.70b 
ethyl acetate 17.67b 6.93c 2.39cd 4.51 cd 42.25a 5.34cd ND ND ND 
propionic acidb 
1 DAY 11.21c,x 12.91c,x 14.23c,y 14.76c,y 51.54b,y 21.39c,x 76.00ab,y 106.41 a,y 97.64a,y 
7 DAY 21.20c,x 16.65c,x 60.91 b,x 37.96c,x 81.02b,x 36.28c,x 207.21 a,x 201.86a,x 228.11 a,x 
14 DAY 17.68c,x 25.08c,x 30.52c,y 23.74c,xy 50.10b,y 42.05b,x 150.21 a,xy 153.17a,xy 180.93a,x 
"Means in the same row followed by the same superscripts (a-e) are not significantly different (p > 0.05). Means are averages of three replications with data for storage time 
pooled unless interactions between the bacterial culture and storage time were significant (p < 0.05). 
Means in the same column followed by the same letters (x-y) are not significantly different (p > 0.05). 
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Table 3 - Effect of bacterial cultures and inoculation level on acidity and texture of 
yogurts8 
Strain Inoculation 
level 
Titratable acidity 
(g lactic acid 
/100ml yogurt)" 
pH° Viscosity 
(centipoise) 
Degree of 
syneresis (%) 
YC 6 1.01a 4.47ab 116,000ab 10a 
7 1.09a 4.34 be 192,000a 4a 
8 0.83b 4.55a 153,000ab 6a 
LB 6 0.78b 4.65a 71,000b 12a 
7 1.11a 4.26c 135,000ab 6a 
8 0.92a 4.53a 133,000ab 13a 
YC+LB 6 1.01a 4.31 be 147,000ab 7a 
7 1.02a 4.36bc 145,000ab 2a 
8 1.17a 4.17c 156,000ab 1a 
"Means in the same column followed by the same superscripts (a-c) are not significantly different (p > 0.05). Means are 
triplicate analyses of three replications. Data were pooled across storage times. 
'Average titratable acidity of all treatments prior to fermentation was 0.23. 
"Average pH of all treatments prior to fermentation was 5.97. 
Table 4 - Effects of bacterial cultures on the volatile flavor compounds of yogurt3 
Bacterial Cultures 
Flavor Compounds 6YC 7YC 8YC 6LB 7LB 8LB 6(YC+LB) 7(YC+LB) 8(YC+LB) 
Characteristic volatile 
compounds in yogurts 
acetaldehyde 12.46bc 12.72bc 11.39c 17.80ab 20.64a 12.94bc 15.39abc 14.07bc 10.12c 
2,3-butanedione 32.90c 32.66c 37.90bc 107.79a 79.11 abc 77.53abc 70.45abc 67.13abc 89.34ab 
2-propanol 11.95c 15.39bc 69.86a 26.21 be 18.71 be 18.47bc 15.50bc 17.11 be 43.23b 
ethyl pentanoate 6.64c 10.79bc 49.37a 20.63b 13.14b 17.42b 11 .BObc 16.18b 15.69b 
benzaldehyde 9.03c 9.94c 12.41 be 13.96b 19.24a 14.66b 14.30b 14.19b 14.08b 
2,3-pentanedione 12.89ab 11.22b 8.50b 14.21ab 16.93a 13.58ab 14.31ab 13.13ab 12.69ab 
ethyl acetate 23.99 20.4 23.31 23.57 18.51 17.03 18.89 21.2 14.01 
acetic acid 12.55c 14.38bc 19.64ab 19.40ab 12.60c 15.85bc 22.58a 17.82abc 21.84a 
butanoic acid 12.59b 13.03b 18.82a 15.30ab 13.36b 13.52b 15.32ab 14.71ab 14.19ab 
ethyl butanoate 18.41 be 19.03bc 12.56c 26.09ab 29.72a 20.90bc 17.66bc 18.21 be 19.77bc 
2-heptanone 282.50b 267.70b 249.68b 252.26b 216.77b 280.42b 282.44b 273.94b 364.27a 
hexanal 12.74 16.06 15.37 19.26 22.43 17.9 17.06 14.03 15.03 
1-pentanol 476.20a 149.2c 350.0abc 200.6bc 357.6abc 410.6ab 239.3bc 227.8bc 297.0abc 
2-pentylfuran 28.74b 30.56b 54.30b 29.07b 29.94b 62.25b 37.25b 27.55b 140.71a 
methanol 9.90b 13.32b 19.98a 14.10b 10.80b 12.08b 11.23b 10.82b 11.10b 
2-undecanone 78.93ab 86.56a 86.39a 45.98c 69.74abc 57.97bc 79.11ab 86.87a 58.02bc 
2-nonanone 75.98b 100.48a 46.75c 18.91d 24.91 d 33.60cd 82.61b 68.10b 78.78b 
1 -butanol 27.26ab 29.19a 26.65ab 30.19a 24.80ab 29.15a 28.49a 26.97ab 17.52b 
ethyl heptanoate 9.69b 9.86b 11.84b 19.96a 13.09b 9.12b 24.24a 12.45b 9.32b 
octanoic acid 7.58 7.68 8.78 6.97 6.47 7.13 7.69 8.9 8.2 
Untypical volatile 
compounds 
undecanal 36.77c 63.76ab 67.07ab 51.45b 76.54a 67.34ab 44.65bc 46.61 be 48.95bc 
1 -octen-3-ol 28.44c 32.62bc 37.17abc 51 45a 45.87abc 41,78abc 49.65ab 41 .Oôabc 38.47abc 
trans-2-nonenal 12.94b 15.72ab 39.73a 19.39ab 14.97b 9.15b 15.75ab 13.28b 17.14ab 
1 -octanol 10.01 11.2 12.37 16.88 15.6 11.31 12.77 11.51 12.8 
5-nonanone 15.30bc 21.16ab 21.47ab 29.13a 12.64c 11.36c 23.42ab 13.56c 10.97c 
"Means in the same row followed by the same superscripts (a-d) are not significantly different (p > 0.05). Means are averages of three replications with data for storage time 
pooled. 
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GENERAL CONCLUSIONS 
Overall, this study demonstrated 1) probiotic bacteria were able to produce CLA from 
linoleic acid in the model system containing hydrolyzed soy oil (1%) emulsified in non-fat 
dry milk, but not in model systems of unhydrolyzed soy oil (1%) emulsified in non-fat dry 
milk or 1% milk fat. Of all evaluated 11 probiotic bacteria, Propionibacterium freudenreichii 
subsp. shermanii 56, P. freudenreichii subsp. shermanii 51 and P. freudenreichii subsp. 
freudenreichii 23 demonstrated the greatest increase in CLA content. P. freudenreichii 
subsp. shermanii 51 produced the highest cis-9, trans-11 CLA content. The fermentation of 
probiotic bacteria for 24 h was often most effective in increasing CLA content and microbial 
counts. Therefore, the content of CLA during the fermentation was primarily dependent on 
strains of probiotic bacteria and lipid sources in the milk model system. 
2) The incorporation of probiotic bacteria with yogurt culture and unique processing 
methods increased the CLA content of yogurt. Of the probiotic bacteria evaluated, 
Lactobacillus rhamnosus, either alone or in conjunction with yogurt culture, resulted in the 
highest content of CLA. However, the yogurt processed with the propionibacteria alone was 
lower in CLA content than the control yogurt. The addition of yogurt cultures or rennet 
greatly increased the microbial counts and CLA content of yogurts processed with 
propionibacteria at 45 °C. Inoculation concentration of L. rhamnosus and yogurt cultures had 
no significant effect on CLA content of yogurts. The yogurt produced by L. rhamnosus in 
conjunction with yogurt culture with 107 CFU/mL total inoculation level resulted in the high 
content of CLA. In general, the CLA content and microbial counts of yogurts were stable 
over a 14-day storage time at 4 °C. 
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3) The yogurt processed with yogurt cultures, L. rhamnosus, yogurt cultures in 
conjunction with probiotic bacteria demonstrated similar acidity, texture and flavor as the 
control yogurt produced with yogurt cultures. The yogurt processed with the propionibacteria 
alone showed different quality attributes from the control yogurt. In general, the quality 
characteristics of yogurts were stable over a 14-day storage time at 4 °C. Inoculation 
concentration of L. rhamnosus and yogurt cultures had no significant effect on texture, but 
affected acidity and volatile flavor compounds of yogurts. CLA-enriched yogurt products 
with L. rhamnosus or the combination of probiotic bacteria and yogurt cultures showed 
acceptable quality attributes. 
Further research in this area should involve sensory evaluation of yogurt under 
similar conditions as the experiments in this study. Correlations should be made between 
quality attributes (volatile flavor profiles, acidity and texture) and sensory data. Gas 
chromatography-olfactometry (GC-O) is a necessary technique to identify desirable and 
undesirable aromas which have an impact on yogurt flavor. Our research focused on volatile 
flavor compounds in yogurts using instrumental analysis. However, sensory attributes play a 
major role in consumer acceptability. GC-0 will provide more information in improving 
yogurt flavor and increasing the popularity in marketplace. 
Extended studies with longer storage times are needed to definitely determine the 
effects of storage time greater than 15 days on CLA content and quality attributes of yogurt. 
The CLA content of the yogurt throughout the whole shelf-life is important to provide health 
benefits for consumers. 
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Finally, the research may also be important to increase the content of free linoleic 
acid in milk without adding lipids from non-dairy source. Additional processing treatments, 
such as additives, should be studied to further increase CLA formation in dairy products. 
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